<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33807303</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2073-4409</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>10</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Mar</Month>
              <Day>31</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cells</Title>
          <ISOAbbreviation>Cells</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">766</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10040766</ELocationID>
        <Abstract>
          <AbstractText>Sarcoidosis is a multi-system disease of unknown etiology characterized by the formation of granulomas in various organs. It affects people of all ethnic backgrounds and occurs at any time of life but is more frequent in African Americans and Scandinavians and in adults between 30 and 50 years of age. Sarcoidosis can affect any organ with a frequency varying according to ethnicity, sex and age. Intrathoracic involvement occurs in 90% of patients with symmetrical bilateral hilar adenopathy and/or diffuse lung micronodules, mainly along the lymphatic structures which are the most affected system. Among extrapulmonary manifestations, skin lesions, uveitis, liver or splenic involvement, peripheral and abdominal lymphadenopathy and peripheral arthritis are the most frequent with a prevalence of 25-50%. Finally, cardiac and neurological manifestations which can be the initial manifestation of sarcoidosis, as can be bilateral parotitis, nasosinusal or laryngeal signs, hypercalcemia and renal dysfunction, affect less than 10% of patients. The diagnosis is not standardized but is based on three major criteria: a compatible clinical and/or radiological presentation, the histological evidence of non-necrotizing granulomatous inflammation in one or more tissues and the exclusion of alternative causes of granulomatous disease. Certain clinical features are considered to be highly specific of the disease (e.g., Löfgren's syndrome, lupus pernio, Heerfordt's syndrome) and do not require histological confirmation. New diagnostic guidelines were recently published. Specific clinical criteria have been developed for the diagnosis of cardiac, neurological and ocular sarcoidosis. This article focuses on the clinical presentation and the common differentials that need to be considered when appropriate.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sève</LastName>
            <ForeName>Pascal</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0003-3070-3842</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Lyon University Hospital, 69007 Lyon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Université Claude Bernard Lyon 1, Research on Healthcare Performance (RESHAPE), INSERM U1290, 69007 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pacheco</LastName>
            <ForeName>Yves</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University Claude Bernard Lyon 1, F-69007 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Durupt</LastName>
            <ForeName>François</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Lyon University Hospital, 69004 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jamilloux</LastName>
            <ForeName>Yvan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Lyon University Hospital, 69007 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gerfaud-Valentin</LastName>
            <ForeName>Mathieu</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-4245-8039</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Lyon University Hospital, 69007 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Isaac</LastName>
            <ForeName>Sylvie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Lyon University Hospital, 69310 Pierre Bénite, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boussel</LastName>
            <ForeName>Loïc</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Lyon University Hospital, 69004 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Calender</LastName>
            <ForeName>Alain</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Genetics, Lyon University Hospital, 69500 Bron, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Androdias</LastName>
            <ForeName>Géraldine</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Service Sclérose en Plaques, Pathologies de la Myéline et Neuro-Inflammation, Hôpital Neurologique Pierre Wertheimer, Lyon University Hospital, F-69677 Bron, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Valeyre</LastName>
            <ForeName>Dominique</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pneumology, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne et Université Paris 13, Sorbonne Paris Cité, 93008 Bobigny, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El Jammal</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Lyon University Hospital, 69007 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>03</Month>
          <Day>31</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cells</MedlineTA>
        <NlmUniqueID>101600052</NlmUniqueID>
        <ISSNLinking>2073-4409</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009928" MajorTopicYN="N">Organ Specificity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012507" MajorTopicYN="N">Sarcoidosis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">cardiac sarcoidosis</Keyword>
        <Keyword MajorTopicYN="Y">diagnostics</Keyword>
        <Keyword MajorTopicYN="Y">differentials</Keyword>
        <Keyword MajorTopicYN="Y">granulomatosis</Keyword>
        <Keyword MajorTopicYN="Y">neurosarcoidosis</Keyword>
        <Keyword MajorTopicYN="Y">sarcoidosis</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest related to this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>3</Day>
          <Hour>1</Hour>
          <Minute>26</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33807303</ArticleId>
        <ArticleId IdType="pmc">PMC8066110</ArticleId>
        <ArticleId IdType="doi">10.3390/cells10040766</ArticleId>
        <ArticleId IdType="pii">cells10040766</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Besnier E.H. Lupus Pernio de La Face; Synovites Fongueuses (Scrofulo-Tuberculeuses) Symétriques Des Extrémités Supérieures. Ann. Derm. Syph. 1889;10:333–336.</Citation>
        </Reference>
        <Reference>
          <Citation>Sakthivel P., Bruder D. Mechanism of Granuloma Formation in Sarcoidosis. Curr. Opin. Hematol. 2017;24:59–65. doi: 10.1097/MOH.0000000000000301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MOH.0000000000000301</ArticleId>
            <ArticleId IdType="pubmed">27755127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunninghake G., Costabel U. Statement on Sarcoidosis. Am. J. Respir. Crit. Care Med. 1999;160:20. doi: 10.1034/j.1399-3003.1999.14d02.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1034/j.1399-3003.1999.14d02.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arkema E.V., Cozier Y.C. Epidemiology of Sarcoidosis: Current Findings and Future Directions. Ther. Adv. Chronic Dis. 2018;9:227–240. doi: 10.1177/2040622318790197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/2040622318790197</ArticleId>
            <ArticleId IdType="pmc">PMC6196636</ArticleId>
            <ArticleId IdType="pubmed">30364496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rybicki B.A., Major M., Popovich J., Maliank M.J., Lannuzzi M.C. Racial Differences in Sarcoidosis Incidence: A 5-Year Study in a Health Maintenance Organization. Am. J. Epidemiol. 1997;145:234–241. doi: 10.1093/oxfordjournals.aje.a009096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/oxfordjournals.aje.a009096</ArticleId>
            <ArticleId IdType="pubmed">9012596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pereira C.A.C., Dornfeld M.C., Baughman R., Judson M.A. Clinical Phenotypes in Sarcoidosis. Curr. Opin. Pulm. Med. 2014;20:496–502. doi: 10.1097/MCP.0000000000000077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MCP.0000000000000077</ArticleId>
            <ArticleId IdType="pubmed">25035964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valeyre D., Prasse A., Nunes H., Uzunhan Y., Brillet P.-Y., Müller-Quernheim J. Sarcoidosis. Lancet. 2014;383:1155–1167. doi: 10.1016/S0140-6736(13)60680-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(13)60680-7</ArticleId>
            <ArticleId IdType="pubmed">24090799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nunes H., Bouvry D., Soler P., Valeyre D. Sarcoidosis. Orphanet J. Rare Dis. 2007;2:46. doi: 10.1186/1750-1172-2-46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1750-1172-2-46</ArticleId>
            <ArticleId IdType="pmc">PMC2169207</ArticleId>
            <ArticleId IdType="pubmed">18021432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nardi A., Brillet P.-Y., Letoumelin P., Girard F., Brauner M., Uzunhan Y., Naccache J.-M., Valeyre D., Nunes H. Stage IV Sarcoidosis: Comparison of Survival with the General Population and Causes of Death. Eur. Respir. J. 2011;38:1368–1373. doi: 10.1183/09031936.00187410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00187410</ArticleId>
            <ArticleId IdType="pubmed">22075486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swigris J.J., Olson A.L., Huie T.J., Fernandez-Perez E.R., Solomon J., Sprunger D., Brown K.K. Sarcoidosis-Related Mortality in the United States from 1988 to 2007. Am. J. Respir. Crit. Care Med. 2011;183:1524–1530. doi: 10.1164/rccm.201010-1679OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201010-1679OC</ArticleId>
            <ArticleId IdType="pmc">PMC3137141</ArticleId>
            <ArticleId IdType="pubmed">21330454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirkil G., Lower E.E., Baughman R.P. Predictors of Mortality in Pulmonary Sarcoidosis. Chest. 2018;153:105–113. doi: 10.1016/j.chest.2017.07.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2017.07.008</ArticleId>
            <ArticleId IdType="pubmed">28728933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morimoto T., Azuma A., Abe S., Usuki J., Kudoh S., Sugisaki K., Oritsu M., Nukiwa T. Epidemiology of Sarcoidosis in Japan. Eur. Respir. J. 2008;31:372–379. doi: 10.1183/09031936.00075307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00075307</ArticleId>
            <ArticleId IdType="pubmed">17959635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jamilloux Y., Maucort-Boulch D., Kerever S., Gerfaud-Valentin M., Broussolle C., Eb M., Valeyre D., Seve P. Sarcoidosis-Related Mortality in France: A Multiple-Cause-of-Death Analysis. Eur. Respir. J. 2016;48:1700–1709. doi: 10.1183/13993003.00457-2016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.00457-2016</ArticleId>
            <ArticleId IdType="pubmed">27660516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baughman R.P., Teirstein A.S., Judson M.A., Rossman M.D., Yeager H., Bresnitz E.A., DePALO L., Hunninghake G., Iannuzzi M.C., Johns C.J., et al.  Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis. Am. J. Respir. Crit. Care Med. 2001;164:1885–1889. doi: 10.1164/ajrccm.164.10.2104046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/ajrccm.164.10.2104046</ArticleId>
            <ArticleId IdType="pubmed">11734441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P., Carmona E.M., Utz J.P., Ryu J.H., Crowson C.S., Matteson E.L. Epidemiology of Sarcoidosis 1946–2013. Mayo Clin. Proc. 2016;91:183–188. doi: 10.1016/j.mayocp.2015.10.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mayocp.2015.10.024</ArticleId>
            <ArticleId IdType="pmc">PMC4744129</ArticleId>
            <ArticleId IdType="pubmed">26727158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mañá J., Rubio-Rivas M., Villalba N., Marcoval J., Iriarte A., Molina-Molina M., Llatjos R., García O., Martínez-Yélamos S., Vicens-Zygmunt V., et al.  Multidisciplinary Approach and Long-Term Follow-up in a Series of 640 Consecutive Patients with Sarcoidosis: Cohort Study of a 40-Year Clinical Experience at a Tertiary Referral Center in Barcelona, Spain. Medicine. 2017;96:e7595. doi: 10.1097/MD.0000000000007595.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000007595</ArticleId>
            <ArticleId IdType="pmc">PMC5521941</ArticleId>
            <ArticleId IdType="pubmed">28723801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valeyre D., Bernaudin J.-F., Jeny F., Duchemann B., Freynet O., Planès C., Kambouchner M., Nunes H. Pulmonary Sarcoidosis. Clin. Chest Med. 2015;36:631–641. doi: 10.1016/j.ccm.2015.08.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccm.2015.08.006</ArticleId>
            <ArticleId IdType="pubmed">26593138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson M.A. The Diagnosis of Sarcoidosis. Clin. Chest Med. 2008;29:415–427. doi: 10.1016/j.ccm.2008.03.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccm.2008.03.009</ArticleId>
            <ArticleId IdType="pubmed">18539235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drent M., Strookappe B., Hoitsma E., De Vries J. Consequences of Sarcoidosis. Clin. Chest Med. 2015;36:727–737. doi: 10.1016/j.ccm.2015.08.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccm.2015.08.013</ArticleId>
            <ArticleId IdType="pubmed">26593145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drent M., Lower E.E., Vries J.D. Sarcoidosis-Associated Fatigue. Eur. Respir. J. 2012;40:255–263. doi: 10.1183/09031936.00002512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00002512</ArticleId>
            <ArticleId IdType="pubmed">22441750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Vries J., Michielsen H., Van Heck G.L., Drent M. Measuring Fatigue in Sarcoidosis: The Fatigue Assessment Scale (FAS) Br. J. Health Psychol. 2004;9:279–291. doi: 10.1348/1359107041557048.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1348/1359107041557048</ArticleId>
            <ArticleId IdType="pubmed">15296678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baughman R.P., Sparkman B.K., Lower E.E. Six-Minute Walk Test and Health Status Assessment in Sarcoidosis. Chest. 2007;132:207–213. doi: 10.1378/chest.06-2822.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.06-2822</ArticleId>
            <ArticleId IdType="pubmed">17625083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drent M., Wirnsberger R.M., de Vries J., van Dieijen-Visser M.P., Wouters E.F.M., Schols A.M.W.J. Association of Fatigue with an Acute Phase Response in Sarcoidosis. Eur. Respir. J. 1999;13:718. doi: 10.1034/j.1399-3003.1999.13d03.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1034/j.1399-3003.1999.13d03.x</ArticleId>
            <ArticleId IdType="pubmed">10362029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korenromp I.H.E., Heijnen C.J., Vogels O.J.M., van den Bosch J.M.M., Grutters J.C. Characterization of Chronic Fatigue in Patients with Sarcoidosis in Clinical Remission. Chest. 2011;140:441–447. doi: 10.1378/chest.10-2629.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.10-2629</ArticleId>
            <ArticleId IdType="pubmed">21330380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michielsen H.J., Drent M., Peros-Golubicic T., De Vries J. Fatigue Is Associated with Quality of Life in Sarcoidosis Patients. Chest. 2006;130:989–994. doi: 10.1378/chest.130.4.989.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.130.4.989</ArticleId>
            <ArticleId IdType="pubmed">17035429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elfferich M.D., Nelemans P.J., Ponds R.W., Vries J.D., Wijnen P.A., Drent M. Everyday Cognitive Failure in Sarcoidosis: The Prevalence and the Effect of Anti-TNF-α Treatment. RES. 2010;80:212–219. doi: 10.1159/000314225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000314225</ArticleId>
            <ArticleId IdType="pubmed">20431280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crouser E.D., Maier L.A., Wilson K.C., Bonham C.A., Morgenthau A.S., Patterson K.C., Abston E., Bernstein R.C., Blankstein R., Chen E.S., et al.  Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am. J. Respir. Crit. Care Med. 2020;201:e26–e51. doi: 10.1164/rccm.202002-0251ST.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.202002-0251ST</ArticleId>
            <ArticleId IdType="pmc">PMC7159433</ArticleId>
            <ArticleId IdType="pubmed">32293205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Telenti A., Hermans P.E. Idiopathic Granulomatosis Manifesting as Fever of Unknown Origin. Mayo Clin. Proc. 1989;64:44–50. doi: 10.1016/S0025-6196(12)65302-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0025-6196(12)65302-6</ArticleId>
            <ArticleId IdType="pubmed">2911215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N. Engl. J. Med. 2007;357:2153–2165. doi: 10.1056/NEJMra071714.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra071714</ArticleId>
            <ArticleId IdType="pubmed">18032765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson M.A., Thompson B.W., Rabin D.L., Steimel J., Knattereud G.L., Lackland D.T., Rose C., Rand C.S., Baughman R.P., Teirstein A.S. The Diagnostic Pathway to Sarcoidosis*. Chest. 2003;123:406–412. doi: 10.1378/chest.123.2.406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.123.2.406</ArticleId>
            <ArticleId IdType="pubmed">12576358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sinha A., Lee K.K., Rafferty G.F., Yousaf N., Pavord I.D., Galloway J., Birring S.S. Predictors of Objective Cough Frequency in Pulmonary Sarcoidosis. Eur. Respir. J. 2016;47:1461–1471. doi: 10.1183/13993003.01369-2015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.01369-2015</ArticleId>
            <ArticleId IdType="pubmed">26846840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeny F., Bernaudin J.-F., Cohen Aubart F., Brillet P.-Y., Bouvry D., Nunes H., Valeyre D. Diagnosis Issues in Sarcoidosis. Respir. Med. Res. 2020;77:37–45. doi: 10.1016/j.resmer.2019.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.resmer.2019.09.002</ArticleId>
            <ArticleId IdType="pubmed">32035337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jameson A., Revels J., Wang L.L., Wang D.T., Wang S.S. Sarcoidosis, the Master Mimicker. Curr. Probl. Diagn. Radiol. 2020:S0363018820301973. doi: 10.1067/j.cpradiol.2020.10.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/j.cpradiol.2020.10.013</ArticleId>
            <ArticleId IdType="pubmed">33308891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venkata Ramanan R., Pudhiavan A., Venkataramanan A. The “Cluster of Black Pearls” Sign of Sarcoid Lymphadenopathy: A New Sign on Thin-Section Contrast-Enhanced Multidetector CT. Clin. Radiol. 2017;72:729–736. doi: 10.1016/j.crad.2017.03.031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.crad.2017.03.031</ArticleId>
            <ArticleId IdType="pubmed">28655404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin S.G., Kronek L.-P., Valeyre D., Brauner N., Brillet P.-Y., Nunes H., Brauner M.W., Réty F. High-Resolution Computed Tomography to Differentiate Chronic Diffuse Interstitial Lung Diseases with Predominant Ground-Glass Pattern Using Logical Analysis of Data. Eur. Radiol. 2010;20:1297–1310. doi: 10.1007/s00330-009-1671-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00330-009-1671-4</ArticleId>
            <ArticleId IdType="pubmed">19997848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valeyre D., Bernaudin J.-F., Uzunhan Y., Kambouchner M., Brillet P.-Y., Soussan M., Nunes H. Clinical Presentation of Sarcoidosis and Diagnostic Work-Up. Semin. Respir. Crit. Care Med. 2014;35:336–351. doi: 10.1055/s-0034-1381229.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0034-1381229</ArticleId>
            <ArticleId IdType="pubmed">25007086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma S.K., Verma U., Pande J.N., Murugesan K., Verma K., Guleria J.S. Glucocorticoid Receptors in Bronchoalveolar Lavage Fluid in Sarcoidosis. Chest. 1988;93:577–579. doi: 10.1378/chest.93.3.577.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.93.3.577</ArticleId>
            <ArticleId IdType="pubmed">3342668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abehsera M., Valeyre D., Grenier P., Jaillet H., Battesti J.P., Brauner M.W. Sarcoidosis with Pulmonary Fibrosis: CT Patterns and Correlation with Pulmonary Function. Am. J. Roentgenol. 2000;174:1751–1757. doi: 10.2214/ajr.174.6.1741751.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/ajr.174.6.1741751</ArticleId>
            <ArticleId IdType="pubmed">10845518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lavergne F., Clerici C., Sadoun D., Brauner M., Battesti J.-P., Valeyre D. Airway Obstruction in Bronchial Sarcoidosis. Chest. 1999;116:1194–1199. doi: 10.1378/chest.116.5.1194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.116.5.1194</ArticleId>
            <ArticleId IdType="pubmed">10559075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chambellan A., Turbie P., Nunes H., Brauner M., Battesti J.-P., Valeyre D. Endoluminal Stenosis of Proximal Bronchi in Sarcoidosis. Chest. 2005;127:472–481. doi: 10.1378/chest.127.2.472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.127.2.472</ArticleId>
            <ArticleId IdType="pubmed">15705984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udwadia Z.F., Pilling J.R., Jenkins P.F., Harrison B.D. Bronchoscopic and Bronchographic Findings in 12 Patients with Sarcoidosis and Severe or Progressive Airways Obstruction. Thorax. 1990;45:272–275. doi: 10.1136/thx.45.4.272.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/thx.45.4.272</ArticleId>
            <ArticleId IdType="pmc">PMC473771</ArticleId>
            <ArticleId IdType="pubmed">2356554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naccache J.-M., Lavolé A., Nunes H., Lamberto C., Letoumelin P., Brauner M., Valeyre D., Brillet P.Y. High-Resolution Computed Tomographic Imaging of Airways in Sarcoidosis Patients With Airflow Obstruction. J. Comput. Assist. Tomogr. 2008;32:905–912. doi: 10.1097/RCT.0b013e31815b63dd.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/RCT.0b013e31815b63dd</ArticleId>
            <ArticleId IdType="pubmed">19204453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wells A.U., Desai S.R., Rubens M.B., Goh N.S.L., Cramer D., Nicholson A.G., Colby T.V., du Bois R.M., Hansell D.M. Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography. Am. J. Respir. Crit. Care Med. 2003;167:962–969. doi: 10.1164/rccm.2111053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.2111053</ArticleId>
            <ArticleId IdType="pubmed">12663338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walsh S.L., Wells A.U., Sverzellati N., Keir G.J., Calandriello L., Antoniou K.M., Copley S.J., Devaraj A., Maher T.M., Renzoni E., et al.  An Integrated Clinicoradiological Staging System for Pulmonary Sarcoidosis: A Case-Cohort Study. Lancet Respir. Med. 2014;2:123–130. doi: 10.1016/S2213-2600(13)70276-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2213-2600(13)70276-5</ArticleId>
            <ArticleId IdType="pubmed">24503267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delobbe A., Hélène P., Jocelyne M., Sophie R., Claude H.-F., Benoît W., Bernard A. Impaired Exercise Response in Sarcoid Patients with Normal Pulmonary Function. Sarcoidosis Vasc. Diffus. Lung Dis. 2002;19:148–153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12102611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marcellis R.G.J., Lenssen A.F., de Vries G.J., Baughman R.P., van der Grinten C.P., Verschakelen J.A., De Vries J., Drent M. Is There an Added Value of Cardiopulmonary Exercise Testing in Sarcoidosis Patients? Lung. 2013;191:43–52. doi: 10.1007/s00408-012-9432-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00408-012-9432-6</ArticleId>
            <ArticleId IdType="pubmed">23138855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallaert B., Talleu C., Wemeau-Stervinou L., Duhamel A., Robin S., Aguilaniu B. Reduction of Maximal Oxygen Uptake in Sarcoidosis: Relationship with Disease Severity. Respiration. 2011;82:501–508. doi: 10.1159/000330050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000330050</ArticleId>
            <ArticleId IdType="pubmed">21934275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopes A.J., Menezes S.L.S., Dias C.M., Oliveira J.F., Mainenti M.R.M., Guimarães F.S. Cardiopulmonary Exercise Testing Variables as Predictors of Long-Term Outcome in Thoracic Sarcoidosis. Braz. J. Med. Biol. Res. 2012;45:256–263. doi: 10.1590/S0100-879X2012007500018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0100-879X2012007500018</ArticleId>
            <ArticleId IdType="pmc">PMC3854197</ArticleId>
            <ArticleId IdType="pubmed">22331135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kollert F., Geck B., Suchy R., Jörres R.A., Arzt M., Heidinger D., Hamer O.W., Prasse A., Müller-Quernheim J., Pfeifer M., et al.  The Impact of Gas Exchange Measurement during Exercise in Pulmonary Sarcoidosis. Respir. Med. 2011;105:122–129. doi: 10.1016/j.rmed.2010.09.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2010.09.007</ArticleId>
            <ArticleId IdType="pubmed">20926272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costabel U., Bonella F., Ohshimo S., Guzman J. Diagnostic Modalities in Sarcoidosis: BAL, EBUS, and PET. Semin. Respir. Crit. Care Med. 2010;31:404–408. doi: 10.1055/s-0030-1262207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0030-1262207</ArticleId>
            <ArticleId IdType="pubmed">20665390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darlington P., Kullberg S., Eklund A., Grunewald J. Subpopulations of Cells from Bronchoalveolar Lavage Can Predict Prognosis in Sarcoidosis. Eur. Respir. J. 2020;55:1901450. doi: 10.1183/13993003.01450-2019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.01450-2019</ArticleId>
            <ArticleId IdType="pmc">PMC6991162</ArticleId>
            <ArticleId IdType="pubmed">31439687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mota P.C., Morais A., Palmares C., Beltrão M., Melo N., Santos A.C., Delgado L. Diagnostic Value of CD103 Expression in Bronchoalveolar Lymphocytes in Sarcoidosis. Respir. Med. 2012;106:1014–1020. doi: 10.1016/j.rmed.2012.03.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2012.03.020</ArticleId>
            <ArticleId IdType="pubmed">22537923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heron M., Slieker W.A.T., Zanen P., van Lochem E.G., Hooijkaas H., van den Bosch J.M.M., van Velzen-Blad H. Evaluation of CD103 as a Cellular Marker for the Diagnosis of Pulmonary Sarcoidosis. Clin. Immunol. 2008;126:338–344. doi: 10.1016/j.clim.2007.11.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clim.2007.11.005</ArticleId>
            <ArticleId IdType="pubmed">18182176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boucly A., Weatherald J., Savale L., Jaïs X., Cottin V., Prevot G., Picard F., de Groote P., Jevnikar M., Bergot E., et al.  Risk Assessment, Prognosis and Guideline Implementation in Pulmonary Arterial Hypertension. Eur. Respir. J. 2017;50:1700889. doi: 10.1183/13993003.00889-2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.00889-2017</ArticleId>
            <ArticleId IdType="pubmed">28775050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubio-Rivas M., Franco J., Corbella X. Sarcoidosis Presenting with and without Löfgren’s Syndrome: Clinical, Radiological and Behavioral Differences Observed in a Group of 691 Patients. Jt. Bone Spine. 2020;87:141–147. doi: 10.1016/j.jbspin.2019.10.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jbspin.2019.10.001</ArticleId>
            <ArticleId IdType="pubmed">31606494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karakaya B., Kaiser Y., van Moorsel C., Grunewald J. Löfgren’s Syndrome: Diagnosis, Management, and Disease Pathogenesis. Semin. Respir. Crit. Care Med. 2017;38:463–476. doi: 10.1055/s-0037-1602380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0037-1602380</ArticleId>
            <ArticleId IdType="pubmed">28750461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goussault C., Albert J.-D., Coiffier G., Lamer F., Guillin R., Le Goff B., Bouvard B., Dernis E., Ferreyra M., Cormier G., et al.  Ultrasound Characterization of Ankle Involvement in Löfgren Syndrome. Jt. Bone Spine. 2018;85:65–69. doi: 10.1016/j.jbspin.2017.03.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jbspin.2017.03.004</ArticleId>
            <ArticleId IdType="pubmed">28343011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anandacoomarasamy A., Peduto A., Howe G., Maniolos N., Spencer D. Magnetic Resonance Imaging in Löfgren’s Syndrome: Demonstration of Periarthritis. Clin. Rheumatol. 2006;26:572–575. doi: 10.1007/s10067-006-0360-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-006-0360-9</ArticleId>
            <ArticleId IdType="pubmed">16897117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cacciatore C., Belnou P., Thietart S., Desthieux C., Versini M., Abisror N., Ottaviani S., Cormier G., Deroux A., Dellal A., et al.  Acute and Chronic Sarcoid Arthropathies: Characteristics and Treatments From a Retrospective Nationwide French Study. Front. Med. 2020;7:565420. doi: 10.3389/fmed.2020.565420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmed.2020.565420</ArticleId>
            <ArticleId IdType="pmc">PMC7758528</ArticleId>
            <ArticleId IdType="pubmed">33363181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bechman K., Christidis D., Walsh S., Birring S.S., Galloway J. A Review of the Musculoskeletal Manifestations of Sarcoidosis. Rheumatology. 2018;57:777–783. doi: 10.1093/rheumatology/kex317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/kex317</ArticleId>
            <ArticleId IdType="pubmed">28968840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sweiss N., Patterson K., Sawaqed R., Jabbar U., Korsten P., Hogarth K., Wollman R., Garcia J., Niewold T., Baughman R. Rheumatologic Manifestations of Sarcoidosis. Semin. Respir. Crit. Care Med. 2010;31:463–473. doi: 10.1055/s-0030-1262214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0030-1262214</ArticleId>
            <ArticleId IdType="pmc">PMC3314339</ArticleId>
            <ArticleId IdType="pubmed">20665396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Visser H. Sarcoid Arthritis: Clinical Characteristics, Diagnostic Aspects, and Risk Factors. Ann. Rheum. Dis. 2002;61:499–504. doi: 10.1136/ard.61.6.499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/ard.61.6.499</ArticleId>
            <ArticleId IdType="pmc">PMC1754119</ArticleId>
            <ArticleId IdType="pubmed">12006321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobak S., Sever F., Usluer O., Goksel T., Orman M. The Clinical Characteristics of Sarcoid Arthropathy Based on a Prospective Cohort Study. Ther. Adv. Musculoskelet. Dis. 2016;8:220–224. doi: 10.1177/1759720X16670598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1759720X16670598</ArticleId>
            <ArticleId IdType="pmc">PMC5322860</ArticleId>
            <ArticleId IdType="pubmed">28255335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sukenik S., Hendler N., Yerushalmi B., Buskila D., Liberman N. Jaccoud’s-Type Arthropathy: An Association with Sarcoidosis. J. Rheumatol. 1991;18:915–917.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1895277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erb N., Cushley M.J., Kassimos D.G., Shave R.M., Kitas G.D. An Assessment of Back Pain and the Prevalence of Sacroiliitis in Sarcoidosis. Chest. 2005;127:192–196. doi: 10.1378/chest.127.1.192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.127.1.192</ArticleId>
            <ArticleId IdType="pubmed">15653983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sparks J.A., McSparron J.I., Shah N., Aliabadi P., Paulson V., Fanta C.H., Coblyn J.S. Osseous Sarcoidosis: Clinical Characteristics, Treatment, and Outcomes—Experience from a Large, Academic Hospital. Semin. Arthritis Rheum. 2014;44:371–379. doi: 10.1016/j.semarthrit.2014.07.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semarthrit.2014.07.003</ArticleId>
            <ArticleId IdType="pubmed">25129260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mostard R.L., Prompers L., Weijers R.E., van Kroonenburgh M.J., Wijnen P.A., Geusens P.P., Drent M. F-18 FDG PET/CT for Detecting Bone and Bone Marrow Involvement in Sarcoidosis Patients. Clin. Nucl. Med. 2012;37:21–25. doi: 10.1097/RLU.0b013e3182335f9b.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/RLU.0b013e3182335f9b</ArticleId>
            <ArticleId IdType="pubmed">22157023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rúa-Figueroa I., Gantes M.A., Erausquin C., Mhaidli H., Montesdeoca A. Vertebral Sarcoidosis: Clinical and Imaging Findings. Semin. Arthritis Rheum. 2002;31:346–352. doi: 10.1053/sarh.2002.31553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/sarh.2002.31553</ArticleId>
            <ArticleId IdType="pubmed">11965598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demaria L., Borie R., Benali K., Piekarski E., Goossens G., Palazzo E., Florien M., Dieudé P., Crestani B., Ottaviani S. 18F-FDG PET/CT in Bone Sarcoidosis: An Observational Study. Clin. Rheumatol. 2020;39:2727–2734. doi: 10.1007/s10067-020-05022-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-020-05022-6</ArticleId>
            <ArticleId IdType="pubmed">32198555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berger C., Sommer C., Meinck H.-M. Isolated Sarcoid Myopathy. Muscle Nerve. 2002;26:553–556. doi: 10.1002/mus.10220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mus.10220</ArticleId>
            <ArticleId IdType="pubmed">12362424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Douglas A.C., Macleod J.G., Matthews J.D. Symptomatic Sarcoidosis of Skeletal Muscle. J. Neurol. Neurosurg. Psychiatry. 1973;36:7. doi: 10.1136/jnnp.36.6.1034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.36.6.1034</ArticleId>
            <ArticleId IdType="pmc">PMC1083605</ArticleId>
            <ArticleId IdType="pubmed">4772718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silverstein A., Siltzbach L.E. Muscle Involvement in Sarcoidosis. Arch. Neurol. 1969;21:7. doi: 10.1001/archneur.1969.00480150025002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneur.1969.00480150025002</ArticleId>
            <ArticleId IdType="pubmed">5802453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe S.M., Pinals R.S., Aelion J.A., Goodman R.E. Myopathy in Sarcoidosis: Clinical and Pathologic Study of Four Cases and Review of the Literature. Semin. Arthritis Rheum. 1987;16:300–306. doi: 10.1016/0049-0172(87)90008-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0049-0172(87)90008-4</ArticleId>
            <ArticleId IdType="pubmed">3299715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cremers J.P., Van Kroonenburgh M.J., Mostard R.L., Vöö S.A., Wijnen P.A., Koek G.H., Drent M. Extent of Disease Activity Assessed by 18F-FDG PET/CT in a Dutch Sarcoidosis Population. Sarcoidosis Vasc. Diffus. Lung Dis. 2014;31:37–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24751452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roux K.L., Streichenberger N., Vial C., Petiot P., Feasson L., Bouhour F., Ninet J., Lachenal F., Broussolle C., Sève P. Granulomatous Myositis: A Clinical Study of Thirteen Cases. Muscle Nerve. 2007;35:171–177. doi: 10.1002/mus.20683.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mus.20683</ArticleId>
            <ArticleId IdType="pubmed">17068767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Androdias G., Maillet D., Marignier R., Pinede L., Confavreux C., Broussolle C., Vukusic S., Seve P. Mycophenolate Mofetil May Be Effective in CNS Sarcoidosis but Not in Sarcoid Myopathy. Neurology. 2011;76:1168–1172. doi: 10.1212/WNL.0b013e318212aafb.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0b013e318212aafb</ArticleId>
            <ArticleId IdType="pubmed">21444902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dieudonné Y., Allenbach Y., Benveniste O., Leonard-Louis S., Hervier B., Mariampillai K., Nespola B., Lannes B., Echaniz-Laguna A., Wendling D., et al.  Granulomatosis-Associated Myositis: High Prevalence of Sporadic Inclusion Body Myositis. Neurology. 2020;94:e910–e920. doi: 10.1212/WNL.0000000000008863.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000008863</ArticleId>
            <ArticleId IdType="pubmed">31882529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P., Crowson C.S., Matteson E.L. Influence of Gender on Epidemiology and Clinical Manifestations of Sarcoidosis: A Population-Based Retrospective Cohort Study 1976-2013. Lung. 2017;195:87–91. doi: 10.1007/s00408-016-9952-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00408-016-9952-6</ArticleId>
            <ArticleId IdType="pmc">PMC5291820</ArticleId>
            <ArticleId IdType="pubmed">27709291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>James D.G., Neville E., Siltzbach L.E., Turiaf J., Battesti J.P., Sharma O.P., Hosoda Y., Mikami R., Odaka M., Villar T.G., et al.  A Worldwide Review of Sarcoidosis*. Ann. N. Y. Acad. Sci. 1976;278:321–334. doi: 10.1111/j.1749-6632.1976.tb47043.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1749-6632.1976.tb47043.x</ArticleId>
            <ArticleId IdType="pubmed">1067017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Studdy P.R., Bird R., Neville E., James D.G. Biochemical Findings in Sarcoidosis. J. Clin. Pathol. 1980;33:528–533. doi: 10.1136/jcp.33.6.528.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jcp.33.6.528</ArticleId>
            <ArticleId IdType="pmc">PMC1146136</ArticleId>
            <ArticleId IdType="pubmed">6249857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baughman R.P., Janovcik J., Ray M., Sweiss N., Lower E.E. Calcium and Vitamin D Metabolism in Sarcoidosis. Sarcoidosis Vasc. Diffus. Lung Dis. 2013;30:113–120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24071882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gwadera Ł., Białas A.J., Iwański M.A., Górski P., Piotrowski W.J. Sarcoidosis and Calcium Homeostasis Disturbances—Do We Know Where We Stand? Chron. Respir. Dis. 2019;16 doi: 10.1177/1479973119878713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1479973119878713</ArticleId>
            <ArticleId IdType="pmc">PMC6854763</ArticleId>
            <ArticleId IdType="pubmed">31718265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adams J.S. Vitamin D Metabolite-Mediated Hypercalcemia. Endocrinol. Metab. Clin. N. Am. 1989;18:765–778. doi: 10.1016/S0889-8529(18)30365-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0889-8529(18)30365-7</ArticleId>
            <ArticleId IdType="pubmed">2673772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caplan A., Rosenbach M., Imadojemu S. Cutaneous Sarcoidosis. Semin. Respir. Crit. Care Med. 2020;41:689–699. doi: 10.1055/s-0040-1713130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0040-1713130</ArticleId>
            <ArticleId IdType="pubmed">32593176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marcoval J., Mañá J., Rubio M. Specific Cutaneous Lesions in Patients with Systemic Sarcoidosis: Relationship to Severity and Chronicity of Disease. Clin. Exp. Dermatol. 2011;36:739–744. doi: 10.1111/j.1365-2230.2011.04128.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2230.2011.04128.x</ArticleId>
            <ArticleId IdType="pubmed">21790725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haimovic A., Sanchez M., Judson M.A., Prystowsky S. Sarcoidosis: A Comprehensive Review and Update for the Dermatologist. J. Am. Acad. Dermatol. 2012;66:719.e1–719.e10. doi: 10.1016/j.jaad.2012.02.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaad.2012.02.003</ArticleId>
            <ArticleId IdType="pubmed">22507586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bodaghi B., Touitou V., Fardeau C., Chapelon C., LeHoang P. Ocular Sarcoidosis. La Presse Médicale. 2012;41:e349–e354. doi: 10.1016/j.lpm.2012.04.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lpm.2012.04.004</ArticleId>
            <ArticleId IdType="pubmed">22595776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jamilloux Y., Kodjikian L., Broussolle C., Sève P. Sarcoidosis and Uveitis. Autoimmun. Rev. 2014;13:840–849. doi: 10.1016/j.autrev.2014.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autrev.2014.04.001</ArticleId>
            <ArticleId IdType="pubmed">24704868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coulon C., Kodjikian L., Rochepeau C., Perard L., Jardel S., Burillon C., Broussolle C., Jamilloux Y., Seve P. Ethnicity and Association with Ocular, Systemic Manifestations and Prognosis in 194 Patients with Sarcoid Uveitis. Graefes Arch. Clin. Exp. Ophthalmol. 2019;257:2495–2503. doi: 10.1007/s00417-019-04415-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00417-019-04415-x</ArticleId>
            <ArticleId IdType="pubmed">31302765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birnbaum A.D., French D.D., Mirsaeidi M., Wehrli S. Sarcoidosis in the National Veteran Population. Ophthalmology. 2015;122:934–938. doi: 10.1016/j.ophtha.2015.01.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ophtha.2015.01.003</ArticleId>
            <ArticleId IdType="pmc">PMC4414801</ArticleId>
            <ArticleId IdType="pubmed">25687027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasadhika S., Rosenbaum J.T. Ocular Sarcoidosis. Clin. Chest Med. 2015;36:669–683. doi: 10.1016/j.ccm.2015.08.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccm.2015.08.009</ArticleId>
            <ArticleId IdType="pmc">PMC4662043</ArticleId>
            <ArticleId IdType="pubmed">26593141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma S.P., Rogers S.L., Hall A.J., Hodgson L., Brennan J., Stawell R.J., Lim L.L. Sarcoidosis-Related Uveitis: Clinical Presentation, Disease Course, and Rates of Systemic Disease Progression After Uveitis Diagnosis. Am. J. Ophthalmol. 2019;198:30–36. doi: 10.1016/j.ajo.2018.09.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajo.2018.09.013</ArticleId>
            <ArticleId IdType="pubmed">30243930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greenberg G., Anderson R., Sharpstone P., James D.G. Enlargement of Parotid Gland Due to Sarcoidosis. Br. Med. J. 1964;2:861–862. doi: 10.1136/bmj.2.5413.861.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.2.5413.861</ArticleId>
            <ArticleId IdType="pmc">PMC1816279</ArticleId>
            <ArticleId IdType="pubmed">14185639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darlington P., Tallstedt L., Padyukov L., Kockum I., Cederlund K., Eklund A., Grunewald J. HLA-DRB1* Alleles and Symptoms Associated with Heerfordt’s Syndrome in Sarcoidosis. Eur. Respir. J. 2011 doi: 10.1183/09031936.00025011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00025011</ArticleId>
            <ArticleId IdType="pubmed">21565911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heerfordt C. Über Eine ‘Febris Uveoparotidea Subchronica’ an Der Glandula Parotis Der Uvea Des Auges Lokalisiert Und Häufig Mit Paresen Cerebrospinaler Nerver Kompliziert. Arch. Ophthalmol. 1909;70:254–273.</Citation>
        </Reference>
        <Reference>
          <Citation>Makimoto G., Kawakado K., Nakanishi M., Tamura T., Noda M., Makimoto S., Sato Y., Kuyama S. Heerfordt’s Syndrome Associated with Trigeminal Nerve Palsy and Reversed Halo Sign. Intern. Med. 2020 doi: 10.2169/internalmedicine.6176-20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2169/internalmedicine.6176-20</ArticleId>
            <ArticleId IdType="pubmed">33390492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mikulic S., Patel P., Sheffield S., Kandah F., Velarde G. Heerfordt-Waldenström Syndrome Manifesting as Cardiac Sarcoidosis. Cureus. 2020;12:e10619. doi: 10.7759/cureus.10619.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.10619</ArticleId>
            <ArticleId IdType="pmc">PMC7515795</ArticleId>
            <ArticleId IdType="pubmed">32983747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rochepeau C., Jamilloux Y., Kerever S., Febvay C., Perard L., Broussolle C., Burillon C., Kodjikian L., Seve P. Long-Term Visual and Systemic Prognoses of 83 Cases of Biopsy-Proven Sarcoid Uveitis. Br. J. Ophthalmol. 2017;101:856–861. doi: 10.1136/bjophthalmol-2016-309767.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjophthalmol-2016-309767</ArticleId>
            <ArticleId IdType="pubmed">27888183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sève P., Jamilloux Y., Tilikete C., Gerfaud-Valentin M., Kodjikian L., El Jammal T. Ocular Sarcoidosis. Semin. Respir. Crit. Care Med. 2020;41:673–688. doi: 10.1055/s-0040-1710536.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0040-1710536</ArticleId>
            <ArticleId IdType="pubmed">32777852</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paovic J., Paovic P., Sredovic V., Jovanovic S. Clinical Manifestations, Complications and Treatment of Ocular Sarcoidosis: Correlation between Visual Efficiency and Macular Edema as Seen on Optical Coherence Tomography. Semin. Ophthalmol. 2016:1–8. doi: 10.1080/08820538.2016.1206576.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/08820538.2016.1206576</ArticleId>
            <ArticleId IdType="pubmed">27628176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miserocchi E., Modorati G., Di Matteo F., Galli L., Rama P., Bandello F. Visual Outcome in Ocular Sarcoidosis: Retrospective Evaluation of Risk Factors. Eur. J. Ophthalmol. 2011;21:802–810. doi: 10.5301/EJO.2011.6417.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5301/EJO.2011.6417</ArticleId>
            <ArticleId IdType="pubmed">21374555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dana M.-R., Merayo-Lloves J., Schaumberg D.A., Foster C.S. Prognosticators for Visual Outcome in Sarcoid Uveitis. Ophthalmology. 1996;103:1846–1853. doi: 10.1016/S0161-6420(96)30417-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0161-6420(96)30417-X</ArticleId>
            <ArticleId IdType="pubmed">8942880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rothova A. Ocular Involvement in Sarcoidosis. Br. J. Ophthalmol. 2000;84:110–116. doi: 10.1136/bjo.84.1.110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjo.84.1.110</ArticleId>
            <ArticleId IdType="pmc">PMC1723211</ArticleId>
            <ArticleId IdType="pubmed">10611110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koczman J.J., Rouleau J., Gaunt M., Kardon R.H., Wall M., Lee A.G. Neuro-Ophthalmic Sarcoidosis: The University of Iowa Experience. Semin. Ophthalmol. 2008;23:157–168. doi: 10.1080/08820530802007382.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/08820530802007382</ArticleId>
            <ArticleId IdType="pubmed">18432542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prabhakaran V.C., Saeed P., Esmaeli B., Sullivan T.J., McNab A., Davis G., Valenzuela A., Leibovitch I., Kesler A., Sivak-Callcott J., et al.  Orbital and Adnexal Sarcoidosis. Arch. Ophthalmol. 2007;125:1657–1662. doi: 10.1001/archopht.125.12.1657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archopht.125.12.1657</ArticleId>
            <ArticleId IdType="pubmed">18071118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braswell R.A., Kline L.B. Neuro-Ophthalmologic Manifestations of Sarcoidosis. Int. Ophthalmol. Clin. 2007;47:67–77. doi: 10.1097/IIO.0b013e3181571d65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/IIO.0b013e3181571d65</ArticleId>
            <ArticleId IdType="pubmed">18049281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leclercq M., Langlois V., Girszyn N., Le Besnerais M., Benhamou Y., Levesque H., Muraine M., Gueudry J. Comparison of Conventional Immunosuppressive Drugs versus Anti-TNF-α Agents in Non-Infectious Non-Anterior Uveitis. J. Autoimmun. 2020;113:102481. doi: 10.1016/j.jaut.2020.102481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaut.2020.102481</ArticleId>
            <ArticleId IdType="pubmed">32586650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tadros M., Forouhar F., Wu G.Y. Hepatic Sarcoidosis. J. Clin. Transl. Hepatol. 2013;1:87–93. doi: 10.14218/JCTH.2013.00016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14218/JCTH.2013.00016</ArticleId>
            <ArticleId IdType="pmc">PMC4521279</ArticleId>
            <ArticleId IdType="pubmed">26357609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deutsch-Link S., Fortuna D., Weinberg E.M. A Comprehensive Review of Hepatic Sarcoid. Semin. Liver Dis. 2018;38:284–297. doi: 10.1055/s-0038-1666853.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0038-1666853</ArticleId>
            <ArticleId IdType="pubmed">30041280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson M. Extrapulmonary Sarcoidosis. Semin. Respir. Crit. Care Med. 2007;28:083–101. doi: 10.1055/s-2007-970335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-2007-970335</ArticleId>
            <ArticleId IdType="pubmed">17330194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bihari C., Rastogi A., Kumar N., Rajesh S., Sarin S.K. Hepatic Sarcoidosis: Clinico-Pathological Characterization of Symptomatic Cases. Acta Gastroenterol. Belg. 2015;78:306–313.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26448412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moreno-Merlo F., Wanless I.R., Shimamatsu K., Sherman M., Greig P., Chiasson D. The Role of Granulomatous Phlebitis and Thrombosis in the Pathogenesis of Cirrhosis and Portal Hypertension in Sarcoidosis. Hepatology. 1997;26:554–560. doi: 10.1002/hep.510260304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.510260304</ArticleId>
            <ArticleId IdType="pubmed">9303482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alam I., Levenson S.D., Ferrell L.D., Bass N.M. Diffuse Intrahepatic Biliary Strictures in Sarcoidosis Resembling Sclerosing Cholangitis (Case Report and Review of the Literature) Dig. Dis. Sci. 1997;42:1295–1301. doi: 10.1023/A:1018874612166.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1018874612166</ArticleId>
            <ArticleId IdType="pubmed">9201098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delfosse V., de Leval L., De Roover A., Delwaide J., Honoré P., Boniver J., Detry O. Budd-Chiari Syndrome Complicating Hepatic Sarcoidosis: Definitive Treatment by Liver Transplantation: A Case Report. Transplant. Proc. 2009;41:3432–3434. doi: 10.1016/j.transproceed.2009.09.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.transproceed.2009.09.021</ArticleId>
            <ArticleId IdType="pubmed">19857764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P., Crowson C.S., Simonetto D.A., Matteson E.L. Clinical Characteristics and Outcome of Hepatic Sarcoidosis: A Population-Based Study 1976–2013. Am. J. Gastroenterol. 2017;112:1556–1563. doi: 10.1038/ajg.2017.231.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ajg.2017.231</ArticleId>
            <ArticleId IdType="pmc">PMC5629110</ArticleId>
            <ArticleId IdType="pubmed">28872150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warshauer D.M., Dumbleton S.A., Molina P.L., Yankaskas B.C., Parker L.A., Woosley J.T. Abdominal CT Findings in Sarcoidosis: Radiologic and Clinical Correlation. Radiology. 1994;192:93–98. doi: 10.1148/radiology.192.1.8208972.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiology.192.1.8208972</ArticleId>
            <ArticleId IdType="pubmed">8208972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P., Ryu J.H., Matteson E.L. Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis. Mayo Clin. Proc. Innov. Qual. Outcomes. 2019;3:358–375. doi: 10.1016/j.mayocpiqo.2019.04.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mayocpiqo.2019.04.006</ArticleId>
            <ArticleId IdType="pmc">PMC6713839</ArticleId>
            <ArticleId IdType="pubmed">31485575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Syed U., Alkhawam H., Bakhit M., Companioni R.A.C., Walfish A. Hepatic Sarcoidosis: Pathogenesis, Clinical Context, and Treatment Options. Scand. J. Gastroenterol. 2016;51:1025–1030. doi: 10.1080/00365521.2016.1177856.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00365521.2016.1177856</ArticleId>
            <ArticleId IdType="pubmed">27175775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coash M., Forouhar F., Wu C.H., Wu G.Y. Granulomatous Liver Diseases: A Review. J. Formos. Med. Assoc. 2012;111:3–13. doi: 10.1016/j.jfma.2011.11.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jfma.2011.11.023</ArticleId>
            <ArticleId IdType="pubmed">22333006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lagana S.M., Moreira R.K., Lefkowitch J.H. Hepatic Granulomas: Pathogenesis and Differential Diagnosis. Clin. Liver Dis. 2010;14:605–617. doi: 10.1016/j.cld.2010.07.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cld.2010.07.005</ArticleId>
            <ArticleId IdType="pubmed">21055685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaya D.R. Hepatic Granulomas: A 10 Year Single Centre Experience. J. Clin. Pathol. 2003;56:850–853. doi: 10.1136/jcp.56.11.850.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jcp.56.11.850</ArticleId>
            <ArticleId IdType="pmc">PMC1770104</ArticleId>
            <ArticleId IdType="pubmed">14600131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geri G., Cacoub P. Granulomatose hépatique. Rev. Méd. Interne. 2011;32:560–566. doi: 10.1016/j.revmed.2010.06.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.revmed.2010.06.017</ArticleId>
            <ArticleId IdType="pubmed">20832918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wainwright H. Hepatic Granulomas. Eur. J. Gastroenterol. Hepatol. 2007;19:93–95. doi: 10.1097/MEG.0b013e3280115523.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MEG.0b013e3280115523</ArticleId>
            <ArticleId IdType="pubmed">17272991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Esfeh J.M., Culver D., Plesec T., John B. Clinical Presentation and Protocol for Management of Hepatic Sarcoidosis. Expert Rev. Gastroenterol. Hepatol. 2015;9:349–358. doi: 10.1586/17474124.2015.958468.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/17474124.2015.958468</ArticleId>
            <ArticleId IdType="pubmed">25473783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Britt A.R., Francis I.R., Glazer G.M., Ellis J.H. Sarcoidosis: Abdominal Manifestations at CT. Radiology. 1991;178:91–94. doi: 10.1148/radiology.178.1.1984330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiology.178.1.1984330</ArticleId>
            <ArticleId IdType="pubmed">1984330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Folz S.J., Johnson C.D., Swensen S.J. Abdominal Manifestations of Sarcoidosis in CT Studies. J. Comput. Assist. Tomogr. 1995;19:573–579. doi: 10.1097/00004728-199507000-00013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00004728-199507000-00013</ArticleId>
            <ArticleId IdType="pubmed">7622687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warshauer D.M., Molina P.L., Hamman S.M., Koehler R.E., Paulson E.K., Bechtold R.E., Perlmutter M.L., Hiken J.N., Francis I.R., Cooper C.J. Nodular Sarcoidosis of the Liver and Spleen: Analysis of 32 Cases. Radiology. 1995;195:757–762. doi: 10.1148/radiology.195.3.7754007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiology.195.3.7754007</ArticleId>
            <ArticleId IdType="pubmed">7754007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tetikkurt C., Yanardag H., Pehlivan M., Bilir M. Clinical Features and Prognostic Significance of Splenic Involvement in Sarcoidosis. Monaldi Arch. Chest Dis. 2017;87 doi: 10.4081/monaldi.2017.893.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4081/monaldi.2017.893</ArticleId>
            <ArticleId IdType="pubmed">29424195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warshauer D.M., Lee J.K.T. Imaging Manifestations of Abdominal Sarcoidosis. Am. J. Roentgenol. 2004;182:15–28. doi: 10.2214/ajr.182.1.1820015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/ajr.182.1.1820015</ArticleId>
            <ArticleId IdType="pubmed">14684507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tana C., Donatiello I., Coppola M.G., Ricci F., Maccarone M.T., Ciarambino T., Cipollone F., Giamberardino M.A. CT Findings in Pulmonary and Abdominal Sarcoidosis. Implications for Diagnosis and Classification. J. Clin. Med. 2020;9:3028.  doi: 10.3390/jcm9093028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9093028</ArticleId>
            <ArticleId IdType="pmc">PMC7565100</ArticleId>
            <ArticleId IdType="pubmed">32962242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghrenassia E., Mekinian A., Chapelon-Albric C., Levy P., Cosnes J., Sève P., Lefèvre G., Dhôte R., Launay D., Prendki V., et al.  Digestive-Tract Sarcoidosis: French Nationwide Case-Control Study of 25 Cases. Medicine. 2016;95:e4279. doi: 10.1097/MD.0000000000004279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000004279</ArticleId>
            <ArticleId IdType="pmc">PMC5265782</ArticleId>
            <ArticleId IdType="pubmed">27442665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munker M., Sharma O.P. Fatal Gastrointestinal Haemorrhage in Sarcoidosis: A Previously Unreported Occurrence. Sarcoidosis. 1987;4:55–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3495838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inomata M., Ikushima S., Awano N., Kondoh K., Satake K., Masuo M., Moriya A., Kamiya H., Ando T., Azuma A., et al.  Upper Gastrointestinal Sarcoidosis: Report of Three Cases. Intern. Med. 2012;51:1689–1694. doi: 10.2169/internalmedicine.51.7367.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2169/internalmedicine.51.7367</ArticleId>
            <ArticleId IdType="pubmed">22790127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubio-Rivas M., Corbella X. Clinical Phenotypes and Prediction of Chronicity in Sarcoidosis Using Cluster Analysis in a Prospective Cohort of 694 Patients. Eur. J. Intern. Med. 2020;77:59–65. doi: 10.1016/j.ejim.2020.04.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejim.2020.04.024</ArticleId>
            <ArticleId IdType="pubmed">32331839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schupp J.C., Freitag-Wolf S., Bargagli E., Mihailović-Vučinić V., Rottoli P., Grubanovic A., Müller A., Jochens A., Tittmann L., Schnerch J., et al.  Phenotypes of Organ Involvement in Sarcoidosis. Eur. Respir. J. 2018;51:1700991. doi: 10.1183/13993003.00991-2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.00991-2017</ArticleId>
            <ArticleId IdType="pubmed">29371378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chapelon-Abric C., De Zuttere D., Duhaut P., Veyssier P., Wechsler B., Huong D.L.T., De Gennes C., Papo T., Blétry O., Godeau P., et al.  Cardiac Sarcoidosis: A Retrospective Study of 41 Cases. Medicine. 2004;83:315–334. doi: 10.1097/01.md.0000145367.17934.75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.md.0000145367.17934.75</ArticleId>
            <ArticleId IdType="pubmed">15525844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han Y.S., Rivera-Grana E., Salek S., Rosenbaum J.T. Distinguishing Uveitis Secondary to Sarcoidosis From Idiopathic Disease: Cardiac Implications. Jama Ophthalmol. 2018;136:109. doi: 10.1001/jamaophthalmol.2017.5466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaophthalmol.2017.5466</ArticleId>
            <ArticleId IdType="pmc">PMC5838604</ArticleId>
            <ArticleId IdType="pubmed">29327057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birnie D.H., Sauer W.H., Bogun F., Cooper J.M., Culver D.A., Duvernoy C.S., Judson M.A., Kron J., Mehta D., Cosedis Nielsen J., et al.  HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated with Cardiac Sarcoidosis. Heart Rhythm. 2014;11:1304–1323. doi: 10.1016/j.hrthm.2014.03.043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.hrthm.2014.03.043</ArticleId>
            <ArticleId IdType="pubmed">24819193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehta D., Lubitz S.A., Frankel Z., Wisnivesky J.P., Einstein A.J., Goldman M., Machac J., Teirstein A. Cardiac Involvement in Patients with Sarcoidosis: Diagnostic and Prognostic Value of Outpatient Testing. Chest. 2008;133:1426–1435. doi: 10.1378/chest.07-2784.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.07-2784</ArticleId>
            <ArticleId IdType="pubmed">18339784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kouranos V., Tzelepis G.E., Rapti A., Mavrogeni S., Aggeli K., Douskou M., Prasad S., Koulouris N., Sfikakis P., Wells A., et al.  Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis. JACC Cardiovasc. Imaging. 2017;10:1437–1447. doi: 10.1016/j.jcmg.2016.11.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcmg.2016.11.019</ArticleId>
            <ArticleId IdType="pubmed">28330653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silverman K.J., Hutchins G.M., Bulkley B.H. Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis. Circulation. 1978;58:1204–1211. doi: 10.1161/01.CIR.58.6.1204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.58.6.1204</ArticleId>
            <ArticleId IdType="pubmed">709777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwai K., Tachibana T., Takemura T., Matsui Y., Kitalchi M., Kawabata Y. Pathological Studies on Sarcoidosis Autopsy. I. Epidemiological Features of 320 Cases in Japan. Pathol. Int. 1993;43:372–376. doi: 10.1111/j.1440-1827.1993.tb01148.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1827.1993.tb01148.x</ArticleId>
            <ArticleId IdType="pubmed">8372682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nunes H., Freynet O., Naggara N., Soussan M., Weinman P., Diebold B., Brillet P.-Y., Valeyre D. Cardiac Sarcoidosis. Semin. Respir. Crit. Care Med. 2010;31:428–441. doi: 10.1055/s-0030-1262211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0030-1262211</ArticleId>
            <ArticleId IdType="pubmed">20665393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kandolin R., Lehtonen J., Airaksinen J., Vihinen T., Miettinen H., Ylitalo K., Kaikkonen K., Tuohinen S., Haataja P., Kerola T., et al.  Cardiac Sarcoidosis: Epidemiology, Characteristics, and Outcome over 25 Years in a Nationwide Study. Circulation. 2015;131:624–632. doi: 10.1161/CIRCULATIONAHA.114.011522.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.011522</ArticleId>
            <ArticleId IdType="pubmed">25527698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ribeiro Neto M.L., Jellis C.L., Joyce E., Callahan T.D., Hachamovitch R., Culver D.A. Update on Cardiac Sarcoidosis. Ann. Am. Thorac. Soc. 2019 doi: 10.1513/AnnalsATS.201902-119CME.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1513/AnnalsATS.201902-119CME</ArticleId>
            <ArticleId IdType="pubmed">31322914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Y., Lower E.E., Li H.-P., Costea A., Attari M., Baughman R.P. Cardiac Sarcoidosis: The Impact of Age and Implanted Devices on Survival. Chest. 2017;151:139–148. doi: 10.1016/j.chest.2016.08.1457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2016.08.1457</ArticleId>
            <ArticleId IdType="pubmed">27614001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurmann R. Echocardiography in Sarcoidosis. Curr. Cardiol. Rep. 2018;20:118. doi: 10.1007/s11886-018-1065-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11886-018-1065-9</ArticleId>
            <ArticleId IdType="pubmed">30259211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terasaki F., Yoshinaga K. New Guidelines for Diagnosis of Cardiac Sarcoidosis in Japan. Ann. Nucl. Cardiol. 2017;3:42–45. doi: 10.17996/anc.17-00042.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.17996/anc.17-00042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murtagh G., Laffin L.J., Beshai J.F., Maffessanti F., Bonham C.A., Patel V.A., Yu Z., Addetia K., Mor-Avi V., Moss J.D., et al.  Prognosis of Myocardial Damage in Sarcoidosis Patients with Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance. Circ. Cardiovasc. Imaging. 2016;9:1–9. doi: 10.1161/CIRCIMAGING.115.003738.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCIMAGING.115.003738</ArticleId>
            <ArticleId IdType="pmc">PMC4718184</ArticleId>
            <ArticleId IdType="pubmed">26763280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hulten E., Agarwal V., Cahill M., Cole G., Vita T., Parrish S., Bittencourt M.S., Murthy V.L., Kwong R., Di Carli M.F., et al.  Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis. Circ. Cardiovasc. Imaging. 2016;9:139–148. doi: 10.1161/CIRCIMAGING.116.005001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCIMAGING.116.005001</ArticleId>
            <ArticleId IdType="pmc">PMC5449111</ArticleId>
            <ArticleId IdType="pubmed">27621357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nadel J., Lancefield T., Voskoboinik A., Taylor A.J. Late Gadolinium Enhancement Identified with Cardiacmagnetic Resonance Imaging in Sarcoidosis Patients Is Associated with Long-Term Ventricular Arrhythmia and Sudden Cardiac Death. Eur. Heart J. Cardiovasc. Imaging. 2015;16:634–641. doi: 10.1093/ehjci/jeu294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ehjci/jeu294</ArticleId>
            <ArticleId IdType="pubmed">25617029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shafee M.A., Fukuda K., Wakayama Y., Nakano M., Kondo M., Hasebe Y., Kawana A., Shimokawa H. Delayed Enhancement on Cardiac Magnetic Resonance Imaging Is a Poor Prognostic Factor in Patients with Cardiac Sarcoidosis. J. Cardiol. 2012;60:448–453. doi: 10.1016/j.jjcc.2012.08.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jjcc.2012.08.002</ArticleId>
            <ArticleId IdType="pubmed">22944174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vita T., Okada D.R., Veillet-Chowdhury M., Bravo P.E., Mullins E., Hulten E., Agrawal M., Madan R., Taqueti V.R., Steigner M., et al.  Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Circ. Cardiovasc. Imaging. 2018;11:e007030. doi: 10.1161/CIRCIMAGING.117.007030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCIMAGING.117.007030</ArticleId>
            <ArticleId IdType="pmc">PMC6381829</ArticleId>
            <ArticleId IdType="pubmed">29335272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birnie D., Beanlands R.S.B., Nery P., Aaron S.D., Culver D.A., DeKemp R.A., Gula L., Ha A., Healey J.S., Inoue Y., et al.  Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial (CHASM CS- RCT) Am. Heart J. 2020;220:246–252. doi: 10.1016/j.ahj.2019.10.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ahj.2019.10.003</ArticleId>
            <ArticleId IdType="pmc">PMC7367280</ArticleId>
            <ArticleId IdType="pubmed">31911261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ardehali H., Howard D.L., Hariri A., Qasim A., Hare J.M., Baughman K.L., Kasper E.K. A Positive Endomyocardial Biopsy Result for Sarcoid Is Associated with Poor Prognosis in Patients with Initially Unexplained Cardiomyopathy. Am. Heart J. 2005;150:459–463. doi: 10.1016/j.ahj.2004.10.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ahj.2004.10.006</ArticleId>
            <ArticleId IdType="pubmed">16169324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fritz D., van de Beek D., Brouwer M.C. Clinical Features, Treatment and Outcome in Neurosarcoidosis: Systematic Review and Meta-Analysis. BMC Neurol. 2016;16:220.  doi: 10.1186/s12883-016-0741-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12883-016-0741-x</ArticleId>
            <ArticleId IdType="pmc">PMC5109654</ArticleId>
            <ArticleId IdType="pubmed">27846819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cação G., Branco A., Meireles M., Alves J.E., Mateus A., Silva A.M., Santos E. Neurosarcoidosis According to Zajicek and Scolding Criteria: 15 Probable and Definite Cases, Their Treatment and Outcomes. J. Neurol. Sci. 2017;379:84–88. doi: 10.1016/j.jns.2017.05.055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2017.05.055</ArticleId>
            <ArticleId IdType="pubmed">28716286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kidd D.P. Neurosarcoidosis: Clinical Manifestations, Investigation and Treatment. Pract. Neurol. 2020;20:199–212. doi: 10.1136/practneurol-2019-002349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/practneurol-2019-002349</ArticleId>
            <ArticleId IdType="pubmed">32424017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P., Crowson C.S., Matteson E.L. Characteristics and Long-Term Outcome of Neurosarcoidosis: A Population-Based Study from 1976-2013. Neuroepidemiology. 2017;48:87–94. doi: 10.1159/000477300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000477300</ArticleId>
            <ArticleId IdType="pmc">PMC5575952</ArticleId>
            <ArticleId IdType="pubmed">28601860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P., Matteson E.L. Neurosarcoidosis. Rheum. Dis. Clin. N. Am. 2017;43:593–606. doi: 10.1016/j.rdc.2017.06.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rdc.2017.06.008</ArticleId>
            <ArticleId IdType="pubmed">29061245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Culver D.A., Neto M.L.R., Moss B.P., Willis M.A. Neurosarcoidosis. Semin. Respir. Crit. Care Med. 2017;38:499–513. doi: 10.1055/s-0037-1604165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0037-1604165</ArticleId>
            <ArticleId IdType="pubmed">28750463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joubert B., Chapelon-Abric C., Biard L., Saadoun D., Demeret S., Dormont D., Resche-Rigon M., Cacoub P. Association of Prognostic Factors and Immunosuppressive Treatment With Long-Term Outcomes in Neurosarcoidosis. JAMA Neurol. 2017;74:1336–1344. doi: 10.1001/jamaneurol.2017.2492.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaneurol.2017.2492</ArticleId>
            <ArticleId IdType="pmc">PMC5710577</ArticleId>
            <ArticleId IdType="pubmed">29052709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bridel C., Courvoisier D.S., Vuilleumier N., Lalive P.H. Cerebrospinal Fluid Angiotensin-Converting Enzyme for Diagnosis of Neurosarcoidosis. J. Neuroimmunol. 2015;285:1–3. doi: 10.1016/j.jneuroim.2015.05.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2015.05.020</ArticleId>
            <ArticleId IdType="pubmed">26198911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arun T., Pattison L., Palace J. Distinguishing Neurosarcoidosis from Multiple Sclerosis Based on CSF Analysis: A Retrospective Study. Neurology. 2020;94:e2545–e2554. doi: 10.1212/WNL.0000000000009491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000009491</ArticleId>
            <ArticleId IdType="pubmed">32354749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chazal T., Costopoulos M., Maillart E., Fleury C., Psimaras D., Legendre P., Pineton de Chambrun M., Haroche J., Lubetzki C., Amoura Z., et al.  The Cerebrospinal Fluid CD4/CD8 Ratio and Interleukin-6 and -10 Levels in Neurosarcoidosis: A Multicenter, Pragmatic, Comparative Study. Eur. J. Neurol. 2019;26:1274–1280. doi: 10.1111/ene.13975.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.13975</ArticleId>
            <ArticleId IdType="pubmed">31021023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stern B.J., Aksamit A., Clifford D., Scott T.F. Neurosarcoidosis Study Group Neurologic Presentations of Sarcoidosis. Neurol. Clin. 2010;28:185–198. doi: 10.1016/j.ncl.2009.09.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ncl.2009.09.012</ArticleId>
            <ArticleId IdType="pubmed">19932381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scott T.F., Yandora K., Valeri A., Chieffe C., Schramke C. Aggressive Therapy for Neurosarcoidosis: Long-Term Follow-up of 48 Treated Patients. Arch. Neurol. 2007;64:691–696. doi: 10.1001/archneur.64.5.691.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneur.64.5.691</ArticleId>
            <ArticleId IdType="pubmed">17502468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bogousslavsky J., Hungerbühler J.P., Regli F., Graf H.J. Subacute Myelopathy as the Presenting Manifestation of Sarcoidosis. Acta Neurochir. 1982;65:193–197. doi: 10.1007/BF01405845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF01405845</ArticleId>
            <ArticleId IdType="pubmed">7180597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Durel C.-A., Marignier R., Maucort-Boulch D., Iwaz J., Berthoux E., Ruivard M., André M., Le Guenno G., Pérard L., Dufour J.-F., et al.  Clinical Features and Prognostic Factors of Spinal Cord Sarcoidosis: A Multicenter Observational Study of 20 BIOPSY-PROVEN Patients. J. Neurol. 2016;263:981–990. doi: 10.1007/s00415-016-8092-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-016-8092-5</ArticleId>
            <ArticleId IdType="pubmed">27007482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spencer T.S., Campellone J.V., Maldonado I., Huang N., Usmani Q., Reginato A.J. Clinical and Magnetic Resonance Imaging Manifestations of Neurosarcoidosis. Semin. Arthritis Rheum. 2005;34:649–661. doi: 10.1016/j.semarthrit.2004.07.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semarthrit.2004.07.011</ArticleId>
            <ArticleId IdType="pubmed">15692958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy O., Salazar-Camelo A., Jimenez J., Barreras P., Reyes M., Garcia M., Moller D., Chen E., Pardo C. Clinical and MRI Phenotypes of Sarcoidosis-Associated Myelopathy. Neurol. Neuroimmunol. Neuroinflamm. 2020;7:e722. doi: 10.1212/NXI.0000000000000722.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/NXI.0000000000000722</ArticleId>
            <ArticleId IdType="pmc">PMC7176244</ArticleId>
            <ArticleId IdType="pubmed">32269072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freda P.U., Post K.D. Differential Diagnosis of Sellar Masses. Endocrinol. Metab. Clin. N. Am. 1999;28:81–117. doi: 10.1016/S0889-8529(05)70058-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0889-8529(05)70058-X</ArticleId>
            <ArticleId IdType="pubmed">10207686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Langrand C., Bihan H., Raverot G., Varron L., Androdias G., Borson-Chazot F., Brue T., Cathebras P., Pinede L., Muller G., et al.  Hypothalamo-Pituitary Sarcoidosis: A Multicenter Study of 24 Patients. QJM. 2012;105:981–995. doi: 10.1093/qjmed/hcs121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/qjmed/hcs121</ArticleId>
            <ArticleId IdType="pubmed">22753675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tavee J.O., Karwa K., Ahmed Z., Thompson N., Parambil J., Culver D.A. Sarcoidosis-Associated Small Fiber Neuropathy in a Large Cohort: Clinical Aspects and Response to IVIG and Anti-TNF Alpha Treatment. Respir. Med. 2017;126:135–138. doi: 10.1016/j.rmed.2017.03.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2017.03.011</ArticleId>
            <ArticleId IdType="pubmed">28318820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoitsma E., Reulen J.P.H., de Baets M., Drent M., Spaans F., Faber C.G. Small Fiber Neuropathy: A Common and Important Clinical Disorder. J. Neurol. Sci. 2004;227:119–130. doi: 10.1016/j.jns.2004.08.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2004.08.012</ArticleId>
            <ArticleId IdType="pubmed">15546602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parambil J.G., Tavee J.O., Zhou L., Pearson K.S., Culver D.A. Efficacy of Intravenous Immunoglobulin for Small Fiber Neuropathy Associated with Sarcoidosis. Respir. Med. 2011;105:101–105. doi: 10.1016/j.rmed.2010.09.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2010.09.015</ArticleId>
            <ArticleId IdType="pubmed">20926271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoitsma E., De Vries J., Drent M. The Small Fiber Neuropathy Screening List: Construction and Cross-Validation in Sarcoidosis. Respir. Med. 2011;105:95–100. doi: 10.1016/j.rmed.2010.09.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2010.09.014</ArticleId>
            <ArticleId IdType="pubmed">20889323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hebel R., Dubaniewicz-Wybieralska M., Dubaniewicz A. Overview of Neurosarcoidosis: Recent Advances. J. Neurol. 2015;262:258–267. doi: 10.1007/s00415-014-7482-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-014-7482-9</ArticleId>
            <ArticleId IdType="pmc">PMC4330460</ArticleId>
            <ArticleId IdType="pubmed">25194844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colvin I.B. Audiovestibular Manifestations of Sarcoidosis: A Review of the Literature. Laryngoscope. 2006;116:75–82. doi: 10.1097/01.mlg.0000184580.52723.9f.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.mlg.0000184580.52723.9f</ArticleId>
            <ArticleId IdType="pubmed">16481814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoitsma E., Faber C.G., Drent M., Sharma O.P. Neurosarcoidosis: A Clinical Dilemma. Lancet Neurol. 2004;3:397–407. doi: 10.1016/S1474-4422(04)00805-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(04)00805-1</ArticleId>
            <ArticleId IdType="pubmed">15207796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burns T.M., Dyck P.J.B., Aksamit A.J., Dyck P.J. The Natural History and Long-Term Outcome of 57 Limb Sarcoidosis Neuropathy Cases. J. Neurol. Sci. 2006;244:77–87. doi: 10.1016/j.jns.2006.01.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2006.01.014</ArticleId>
            <ArticleId IdType="pubmed">16524595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jachiet V., Lhote R., Rufat P., Pha M., Haroche J., Crozier S., Dupel-Potier C., Psimaras D., Amoura Z., Cohen Aubart F. Clinical, Imaging, and Histological Presentations and Outcomes of Stroke Related to Sarcoidosis. J. Neurol. 2018;265:2333–2341. doi: 10.1007/s00415-018-9001-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-018-9001-x</ArticleId>
            <ArticleId IdType="pubmed">30109479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahévas M., Lescure F.X., Boffa J.-J., Delastour V., Belenfant X., Chapelon C., Cordonnier C., Makdassi R., Piette J.-C., Naccache J.-M., et al.  Renal Sarcoidosis: Clinical, Laboratory, and Histologic Presentation and Outcome in 47 Patients. Medicine. 2009;88:98–106. doi: 10.1097/MD.0b013e31819de50f.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0b013e31819de50f</ArticleId>
            <ArticleId IdType="pubmed">19282700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cozier Y.C., Berman J.S., Palmer J.R., Boggs D.A., Serlin D.M., Rosenberg L. Sarcoidosis in Black Women in the United States: Data from the Black Women’s Health Study. Chest. 2011;139:144–150. doi: 10.1378/chest.10-0413.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.10-0413</ArticleId>
            <ArticleId IdType="pmc">PMC3014690</ArticleId>
            <ArticleId IdType="pubmed">20595459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson M.A., Boan A.D., Lackland D.T. The Clinical Course of Sarcoidosis: Presentation, Diagnosis, and Treatment in a Large White and Black Cohort in the United States. Sarcoidosis Vasc. Diffus. Lung Dis. 2012;29:119–127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23461074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamata Y., Sato H., Joh K., Tsuchiya Y., Kunugi S., Shimizu A., Konta T., Baughman R.P., Azuma A. Clinical Characteristics of Biopsy-Proven Renal Sarcoidosis in Japan. Sarcoidosis Vasc. Diffus. Lung Dis. 2018;35:252–260. doi: 10.36141/svdld.v35i3.6655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.36141/svdld.v35i3.6655</ArticleId>
            <ArticleId IdType="pmc">PMC7170156</ArticleId>
            <ArticleId IdType="pubmed">32476910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Javaud N., Belenfant X., Stirnemann J., Laederich J., Ziol M., Callard P., Ronco P., Rondeau E., Fain O. Renal Granulomatoses: A Retrospective Study of 40 Cases and Review of the Literature. Medicine. 2007;86:170–180. doi: 10.1097/MD.0b013e3180699f55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0b013e3180699f55</ArticleId>
            <ArticleId IdType="pubmed">17505256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah S., Carter-Monroe N., Atta M.G. Granulomatous Interstitial Nephritis. Clin. Kidney J. 2015;8:516–523. doi: 10.1093/ckj/sfv053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ckj/sfv053</ArticleId>
            <ArticleId IdType="pmc">PMC4581373</ArticleId>
            <ArticleId IdType="pubmed">26413275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clive D.M., Vanguri V.K. The Syndrome of Tubulointerstitial Nephritis With Uveitis (TINU) Am. J. Kidney Dis. 2018;72:118–128. doi: 10.1053/j.ajkd.2017.11.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.ajkd.2017.11.013</ArticleId>
            <ArticleId IdType="pubmed">29429748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bergner R., Hoffmann M., Waldherr R., Uppenkamp M. Frequency of Kidney Disease in Chronic Sarcoidosis. Sarcoidosis Vasc. Diffus. Lung Dis. 2003;20:126–132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12870722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bergner R., Löffler C. Renal Sarcoidosis: Approach to Diagnosis and Management. Curr. Opin. Pulm. Med. 2018;24:513–520. doi: 10.1097/MCP.0000000000000504.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MCP.0000000000000504</ArticleId>
            <ArticleId IdType="pubmed">29965860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mrówka-Kata K., Kata D., Lange D., Namysłowski G., Czecior E., Banert K. Sarcoidosis and Its Otolaryngological Implications. Eur. Arch. Oto-Rhino-Laryngol. Off. J. Eur. Fed. Oto-Rhino-Laryngol. Soc. (Eufos) Affil. Ger. Soc. Oto-Rhino-Laryngol. Head Neck Surg. 2010;267:1507–1514. doi: 10.1007/s00405-010-1331-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00405-010-1331-y</ArticleId>
            <ArticleId IdType="pubmed">20617327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aubart F.C., Ouayoun M., Brauner M., Attali P., Kambouchner M., Valeyre D., Nunes H. Sinonasal Involvement in Sarcoidosis: A Case-Control Study of 20 Patients. Medicine. 2006;85:365–371. doi: 10.1097/01.md.0000236955.79966.07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.md.0000236955.79966.07</ArticleId>
            <ArticleId IdType="pubmed">17108780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawson W., Jiang N., Cheng J. Sinonasal Sarcoidosis: A New System of Classification Acting as a Guide to Diagnosis and Treatment. Am. J. Rhinol. Allergy. 2014;28:317–322. doi: 10.2500/ajra.2014.28.4061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2500/ajra.2014.28.4061</ArticleId>
            <ArticleId IdType="pubmed">25197919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edriss H., Kelley J.S., Demke J., Nugent K. Sinonasal and Laryngeal Sarcoidosis—An Uncommon Presentation and Management Challenge. Am. J. Med. Sci. 2019;357:93–102. doi: 10.1016/j.amjms.2018.11.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjms.2018.11.007</ArticleId>
            <ArticleId IdType="pubmed">30665498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duchemann B., Lavolé A., Naccache J.-M., Nunes H., Benzakin S., Lefevre M., Kambouchner M., Périé S., Valeyre D., Cadranel J. Laryngeal Sarcoidosis: A Case-Control Study. Sarcoidosis Vasc. Diffus. Lung Dis. 2014;31:227–234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25363223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rotman A., Maughan E.F., Rouhani M.J., Holroyd A., Ashcroft M., Al Yaghchi C., Sandhu G. Laryngeal Sarcoidosis at a Tertiary Airway Centre: Our Experience with 32 Patients. Clin. Otolaryngol. 2020 doi: 10.1111/coa.13679.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/coa.13679</ArticleId>
            <ArticleId IdType="pubmed">33274590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lhote R., Annesi-Maesano I., Nunes H., Launay D., Borie R., Sacré K., Schleinitz N., Hamidou M., Mahevas M., Devilliers H., et al.  Clinical Phenotypes of Extrapulmonary Sarcoidosis: An Analysis of a French, Multiethnic, Multicenter Cohort. Eur. Respir. J. 2020:2001160. doi: 10.1183/13993003.01160-2020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.01160-2020</ArticleId>
            <ArticleId IdType="pubmed">33093118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kreider M.E., Christie J.D., Thompson B., Newman L., Rose C., Barnard J., Bresnitz E., Judson M.A., Lackland D.T., Rossman M.D. Relationship of Environmental Exposures to the Clinical Phenotype of Sarcoidosis. Chest. 2005;128:207–215. doi: 10.1016/S0012-3692(15)37948-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0012-3692(15)37948-4</ArticleId>
            <ArticleId IdType="pubmed">16002937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson M.A., Costabel U., Drent M., Wells A., Maier L., Koth L., Shigemitsu H., Culver D.A., Gelfand J., Valeyre D., et al.  The WASOG Sarcoidosis Organ Assessment Instrument: An Update of a Previous Clinical Tool. Sarcoidosis Vasc. Diffus. Lung Dis. 2014;31:19–27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24751450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bickett A.N., Lower E.E., Baughman R.P. Sarcoidosis Diagnostic Score. Chest. 2018;154:1052–1060. doi: 10.1016/j.chest.2018.05.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2018.05.003</ArticleId>
            <ArticleId IdType="pmc">PMC6859250</ArticleId>
            <ArticleId IdType="pubmed">29778660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agrawal A., Ghori U., Chaddha U., Murgu S. Combined EBUS-IFB and EBUS-TBNA vs. EBUS-TBNA Alone for Intrathoracic Adenopathy: A Meta-Analysis. Ann. Thorac. Surg. 2021 doi: 10.1016/j.athoracsur.2020.12.049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.athoracsur.2020.12.049</ArticleId>
            <ArticleId IdType="pubmed">33485918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernard C., Kodjikian L., Bancel B., Isaac S., Broussolle C., Seve P. Ocular Sarcoidosis: When Should Labial Salivary Gland Biopsy Be Performed? Graefes Arch. Clin. Exp. Ophthalmol. 2013;251:855–860. doi: 10.1007/s00417-012-2178-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00417-012-2178-2</ArticleId>
            <ArticleId IdType="pubmed">23100162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blaise P., Fardeau C., Chapelon C., Bodaghi B., Le Hoang P. Minor Salivary Gland Biopsy in Diagnosing Ocular Sarcoidosis. Br. J. Ophthalmol. 2011;95:1731–1734. doi: 10.1136/bjophthalmol-2011-300129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjophthalmol-2011-300129</ArticleId>
            <ArticleId IdType="pubmed">21900225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keijsers R.G.M., Grutters J.C. In Which Patients with Sarcoidosis Is FDG PET/CT Indicated? J. Clin. Med. 2020;9:890.  doi: 10.3390/jcm9030890.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9030890</ArticleId>
            <ArticleId IdType="pmc">PMC7141490</ArticleId>
            <ArticleId IdType="pubmed">32213991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rahmi A., Deshayes E., Maucort-Boulch D., Varron L., Grange J.D., Kodjikian L., Seve P. Intraocular Sarcoidosis: Association of Clinical Characteristics of Uveitis with Findings from 18 F-Labelled Fluorodeoxyglucose Positron Emission Tomography. Br. J. Ophthalmol. 2012;96:99–103. doi: 10.1136/bjo.2010.194514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjo.2010.194514</ArticleId>
            <ArticleId IdType="pubmed">21464036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan J.L., Fong H.K., Birati E.Y., Han Y. Cardiac Sarcoidosis. Am. J. Cardiol. 2019;123:513–522. doi: 10.1016/j.amjcard.2018.10.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjcard.2018.10.021</ArticleId>
            <ArticleId IdType="pubmed">30503798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshinaga K., Miyagawa M., Kiso K., Ishida Y. Japanese Guidelines for Cardiac Sarcoidosis. Ann. Nucl. Cardiol. 2017;3:121–124. doi: 10.17996/anc.17-00029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.17996/anc.17-00029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stern B.J., Royal W., Gelfand J.M., Clifford D.B., Tavee J., Pawate S., Berger J.R., Aksamit A.J., Krumholz A., Pardo C.A., et al.  Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol. 2018;75:1546. doi: 10.1001/jamaneurol.2018.2295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaneurol.2018.2295</ArticleId>
            <ArticleId IdType="pubmed">30167654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herbort C.P., Rao N.A., Mochizuki M. The members of the Scientific Commi International Criteria for the Diagnosis of Ocular Sarcoidosis: Results of the First International Workshop on Ocular Sarcoidosis (IWOS) Ocul. Immunol. Inflamm. 2009;17:160–169. doi: 10.1080/09273940902818861.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09273940902818861</ArticleId>
            <ArticleId IdType="pubmed">19585358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mochizuki M., Smith J.R., Takase H., Kaburaki T., Acharya N.R., Rao N.A. Revised Criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the Diagnosis of Ocular Sarcoidosis. Br. J. Ophthalmol. 2019;103:1418–1422. doi: 10.1136/bjophthalmol-2018-313356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjophthalmol-2018-313356</ArticleId>
            <ArticleId IdType="pubmed">30798264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosen Y. Four Decades of Necrotizing Sarcoid Granulomatosis: What Do We Know Now? Arch. Pathol. Lab. Med. 2015;139:252–262. doi: 10.5858/arpa.2014-0051-RA.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5858/arpa.2014-0051-RA</ArticleId>
            <ArticleId IdType="pubmed">25611109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Criado E., Sánchez M., Ramírez J., Arguis P., de Caralt T.M., Perea R.J., Xaubet A. Pulmonary Sarcoidosis: Typical and Atypical Manifestations at High-Resolution CT with Pathologic Correlation. RadioGraphics. 2010;30:1567–1586. doi: 10.1148/rg.306105512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/rg.306105512</ArticleId>
            <ArticleId IdType="pubmed">21071376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park H.J., Jung J.I., Chung M.H., Song S.W., Kim H.L., Baik J.H., Han D.H., Kim K.J., Lee K.-Y. Typical and Atypical Manifestations of Intrathoracic Sarcoidosis. Korean J. Radiol. 2009;10:623. doi: 10.3348/kjr.2009.10.6.623.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3348/kjr.2009.10.6.623</ArticleId>
            <ArticleId IdType="pmc">PMC2770817</ArticleId>
            <ArticleId IdType="pubmed">19885319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spagnolo P., Luppi F., Roversi P., Cerri S., Fabbri L.M., Richeldi L. Sarcoidosis: Challenging Diagnostic Aspects of an Old Disease. Am. J. Med. 2012;125:118–125. doi: 10.1016/j.amjmed.2011.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjmed.2011.06.003</ArticleId>
            <ArticleId IdType="pubmed">22269612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El Jammal T., Jamilloux Y., Gerfaud-Valentin M., Valeyre D., Sève P. Refractory Sarcoidosis: A Review. TCRM. 2020;16:323–345. doi: 10.2147/TCRM.S192922.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/TCRM.S192922</ArticleId>
            <ArticleId IdType="pmc">PMC7173950</ArticleId>
            <ArticleId IdType="pubmed">32368072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gousseff M., Mechaï F., Lecuit M., Lortholary O. Les granulomatoses systémiques d’origine infectieuse. La Rev. De Médecine Interne. 2008;29:15–27. doi: 10.1016/j.revmed.2007.09.037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.revmed.2007.09.037</ArticleId>
            <ArticleId IdType="pubmed">18054122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piotrowski W.J., Żądło P.P.L.J., Górski W., Kumor-Kisielewska A., Fijałkowski M., Kurmanowska Z., Marczak J., Gwadera Ł., Angowski W., Górski P., et al.  QuantiFERON-TB-GOLD In-Tube in Patients with Sarcoidosis. Adv. Respir. Med. 2018;86:234–239. doi: 10.5603/ARM.2018.0037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5603/ARM.2018.0037</ArticleId>
            <ArticleId IdType="pubmed">30378651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Sullivan C.E., Miller D.R., Schneider P.S., Roberts G.D. Evaluation of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test by Using Respiratory and Nonrespiratory Specimens in a Tertiary Care Center Laboratory. J. Clin. Microbiol. 2002;40:1723–1727. doi: 10.1128/JCM.40.5.1723-1727.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.40.5.1723-1727.2002</ArticleId>
            <ArticleId IdType="pmc">PMC130650</ArticleId>
            <ArticleId IdType="pubmed">11980950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dhooria S., Gupta N., Bal A. Role of Xpert MTB/RIF in Differentiating Tuberculosis from Sarcoidosis in Patients with Mediastinal Lymphadenopathy Undergoing EBUS-TBNA: A Study of 147 Patients. Sarcoidosis Vasc. Diffus. Lung Dis. 2016;33:258–266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27758992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohshimo S., Guzman J., Costabel U., Bonella F. Differential Diagnosis of Granulomatous Lung Disease: Clues and Pitfalls: Number 4 in the Series “Pathology for the Clinician” Edited by Peter Dorfmüller and Alberto Cavazza. Eur. Respir. Rev. 2017;26:170012. doi: 10.1183/16000617.0012-2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/16000617.0012-2017</ArticleId>
            <ArticleId IdType="pubmed">28794143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramos-Casals M., Mañá J., Nardi N., Brito-Zerón P., Xaubet A., Sánchez-Tapias J.M., Cervera R., Font J. Sarcoidosis in Patients With Chronic Hepatitis C Virus Infection: Analysis of 68 Cases. Medicine. 2005;84:69–80. doi: 10.1097/01.md.0000157577.69729.e6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.md.0000157577.69729.e6</ArticleId>
            <ArticleId IdType="pubmed">15758836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chopra A., Nautiyal A., Kalkanis A., Judson M.A. Drug-Induced Sarcoidosis-Like Reactions. Chest. 2018;154:664–677. doi: 10.1016/j.chest.2018.03.056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2018.03.056</ArticleId>
            <ArticleId IdType="pubmed">29698718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen Aubart F., Lhote R., Amoura A., Valeyre D., Haroche J., Amoura Z., Lebrun-Vignes B. Drug-induced Sarcoidosis: An Overview of the WHO Pharmacovigilance Database. J. Intern. Med. 2019 doi: 10.1111/joim.12991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/joim.12991</ArticleId>
            <ArticleId IdType="pubmed">31612562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouvry D., Mouthon L., Brillet P.-Y., Kambouchner M., Ducroix J.-P., Cottin V., Haroche J., Viallard J.-F., Lazor R., Lebargy F., et al.  Granulomatosis-Associated Common Variable Immunodeficiency Disorder: A Case-Control Study versus Sarcoidosis. Eur. Respir. J. 2013;41:115–122. doi: 10.1183/09031936.00189011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00189011</ArticleId>
            <ArticleId IdType="pubmed">22903958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El Jammal T., Pavic M., Gerfaud-Valentin M., Jamilloux Y., Seve P. Sarcoidosis and Cancer: A Complex Relationship. Front. Med. 2020 doi: 10.3389/fmed.2020.594118. Accepted for publication.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmed.2020.594118</ArticleId>
            <ArticleId IdType="pmc">PMC7732692</ArticleId>
            <ArticleId IdType="pubmed">33330555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lococo F., Muoio B., Chiappetta M., Nachira D., Petracca Ciavarella L., Margaritora S., Treglia G. Diagnostic Performance of PET or PET/CT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours According to Published Meta-Analyses. Contrast Media Mol. Imaging. 2020;2020:1–7. doi: 10.1155/2020/5282698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2020/5282698</ArticleId>
            <ArticleId IdType="pmc">PMC7196984</ArticleId>
            <ArticleId IdType="pubmed">32405280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Law L.Y., Riminton D.S., Nguyen M., Barnett M.H., Reddel S.W., Hardy T.A. The Spectrum of Immune-Mediated and Inflammatory Lesions of the Brainstem: Clues to Diagnosis. Neurology. 2019;93:390–405. doi: 10.1212/WNL.0000000000008015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000008015</ArticleId>
            <ArticleId IdType="pubmed">31451586</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33807303</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2073-4409</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>10</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Mar</Month>
              <Day>31</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cells</Title>
          <ISOAbbreviation>Cells</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">766</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10040766</ELocationID>
        <Abstract>
          <AbstractText>Sarcoidosis is a multi-system disease of unknown etiology characterized by the formation of granulomas in various organs. It affects people of all ethnic backgrounds and occurs at any time of life but is more frequent in African Americans and Scandinavians and in adults between 30 and 50 years of age. Sarcoidosis can affect any organ with a frequency varying according to ethnicity, sex and age. Intrathoracic involvement occurs in 90% of patients with symmetrical bilateral hilar adenopathy and/or diffuse lung micronodules, mainly along the lymphatic structures which are the most affected system. Among extrapulmonary manifestations, skin lesions, uveitis, liver or splenic involvement, peripheral and abdominal lymphadenopathy and peripheral arthritis are the most frequent with a prevalence of 25-50%. Finally, cardiac and neurological manifestations which can be the initial manifestation of sarcoidosis, as can be bilateral parotitis, nasosinusal or laryngeal signs, hypercalcemia and renal dysfunction, affect less than 10% of patients. The diagnosis is not standardized but is based on three major criteria: a compatible clinical and/or radiological presentation, the histological evidence of non-necrotizing granulomatous inflammation in one or more tissues and the exclusion of alternative causes of granulomatous disease. Certain clinical features are considered to be highly specific of the disease (e.g., Löfgren's syndrome, lupus pernio, Heerfordt's syndrome) and do not require histological confirmation. New diagnostic guidelines were recently published. Specific clinical criteria have been developed for the diagnosis of cardiac, neurological and ocular sarcoidosis. This article focuses on the clinical presentation and the common differentials that need to be considered when appropriate.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sève</LastName>
            <ForeName>Pascal</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0003-3070-3842</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Lyon University Hospital, 69007 Lyon, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Université Claude Bernard Lyon 1, Research on Healthcare Performance (RESHAPE), INSERM U1290, 69007 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pacheco</LastName>
            <ForeName>Yves</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University Claude Bernard Lyon 1, F-69007 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Durupt</LastName>
            <ForeName>François</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Lyon University Hospital, 69004 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jamilloux</LastName>
            <ForeName>Yvan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Lyon University Hospital, 69007 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gerfaud-Valentin</LastName>
            <ForeName>Mathieu</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0003-4245-8039</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Lyon University Hospital, 69007 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Isaac</LastName>
            <ForeName>Sylvie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Lyon University Hospital, 69310 Pierre Bénite, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boussel</LastName>
            <ForeName>Loïc</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Lyon University Hospital, 69004 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Calender</LastName>
            <ForeName>Alain</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Genetics, Lyon University Hospital, 69500 Bron, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Androdias</LastName>
            <ForeName>Géraldine</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Service Sclérose en Plaques, Pathologies de la Myéline et Neuro-Inflammation, Hôpital Neurologique Pierre Wertheimer, Lyon University Hospital, F-69677 Bron, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Valeyre</LastName>
            <ForeName>Dominique</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pneumology, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne et Université Paris 13, Sorbonne Paris Cité, 93008 Bobigny, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El Jammal</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, Lyon University Hospital, 69007 Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>03</Month>
          <Day>31</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cells</MedlineTA>
        <NlmUniqueID>101600052</NlmUniqueID>
        <ISSNLinking>2073-4409</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009928" MajorTopicYN="N">Organ Specificity</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012507" MajorTopicYN="N">Sarcoidosis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">cardiac sarcoidosis</Keyword>
        <Keyword MajorTopicYN="Y">diagnostics</Keyword>
        <Keyword MajorTopicYN="Y">differentials</Keyword>
        <Keyword MajorTopicYN="Y">granulomatosis</Keyword>
        <Keyword MajorTopicYN="Y">neurosarcoidosis</Keyword>
        <Keyword MajorTopicYN="Y">sarcoidosis</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest related to this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>3</Day>
          <Hour>1</Hour>
          <Minute>26</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33807303</ArticleId>
        <ArticleId IdType="pmc">PMC8066110</ArticleId>
        <ArticleId IdType="doi">10.3390/cells10040766</ArticleId>
        <ArticleId IdType="pii">cells10040766</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Besnier E.H. Lupus Pernio de La Face; Synovites Fongueuses (Scrofulo-Tuberculeuses) Symétriques Des Extrémités Supérieures. Ann. Derm. Syph. 1889;10:333–336.</Citation>
        </Reference>
        <Reference>
          <Citation>Sakthivel P., Bruder D. Mechanism of Granuloma Formation in Sarcoidosis. Curr. Opin. Hematol. 2017;24:59–65. doi: 10.1097/MOH.0000000000000301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MOH.0000000000000301</ArticleId>
            <ArticleId IdType="pubmed">27755127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunninghake G., Costabel U. Statement on Sarcoidosis. Am. J. Respir. Crit. Care Med. 1999;160:20. doi: 10.1034/j.1399-3003.1999.14d02.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1034/j.1399-3003.1999.14d02.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arkema E.V., Cozier Y.C. Epidemiology of Sarcoidosis: Current Findings and Future Directions. Ther. Adv. Chronic Dis. 2018;9:227–240. doi: 10.1177/2040622318790197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/2040622318790197</ArticleId>
            <ArticleId IdType="pmc">PMC6196636</ArticleId>
            <ArticleId IdType="pubmed">30364496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rybicki B.A., Major M., Popovich J., Maliank M.J., Lannuzzi M.C. Racial Differences in Sarcoidosis Incidence: A 5-Year Study in a Health Maintenance Organization. Am. J. Epidemiol. 1997;145:234–241. doi: 10.1093/oxfordjournals.aje.a009096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/oxfordjournals.aje.a009096</ArticleId>
            <ArticleId IdType="pubmed">9012596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pereira C.A.C., Dornfeld M.C., Baughman R., Judson M.A. Clinical Phenotypes in Sarcoidosis. Curr. Opin. Pulm. Med. 2014;20:496–502. doi: 10.1097/MCP.0000000000000077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MCP.0000000000000077</ArticleId>
            <ArticleId IdType="pubmed">25035964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valeyre D., Prasse A., Nunes H., Uzunhan Y., Brillet P.-Y., Müller-Quernheim J. Sarcoidosis. Lancet. 2014;383:1155–1167. doi: 10.1016/S0140-6736(13)60680-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(13)60680-7</ArticleId>
            <ArticleId IdType="pubmed">24090799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nunes H., Bouvry D., Soler P., Valeyre D. Sarcoidosis. Orphanet J. Rare Dis. 2007;2:46. doi: 10.1186/1750-1172-2-46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1750-1172-2-46</ArticleId>
            <ArticleId IdType="pmc">PMC2169207</ArticleId>
            <ArticleId IdType="pubmed">18021432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nardi A., Brillet P.-Y., Letoumelin P., Girard F., Brauner M., Uzunhan Y., Naccache J.-M., Valeyre D., Nunes H. Stage IV Sarcoidosis: Comparison of Survival with the General Population and Causes of Death. Eur. Respir. J. 2011;38:1368–1373. doi: 10.1183/09031936.00187410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00187410</ArticleId>
            <ArticleId IdType="pubmed">22075486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swigris J.J., Olson A.L., Huie T.J., Fernandez-Perez E.R., Solomon J., Sprunger D., Brown K.K. Sarcoidosis-Related Mortality in the United States from 1988 to 2007. Am. J. Respir. Crit. Care Med. 2011;183:1524–1530. doi: 10.1164/rccm.201010-1679OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201010-1679OC</ArticleId>
            <ArticleId IdType="pmc">PMC3137141</ArticleId>
            <ArticleId IdType="pubmed">21330454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirkil G., Lower E.E., Baughman R.P. Predictors of Mortality in Pulmonary Sarcoidosis. Chest. 2018;153:105–113. doi: 10.1016/j.chest.2017.07.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2017.07.008</ArticleId>
            <ArticleId IdType="pubmed">28728933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morimoto T., Azuma A., Abe S., Usuki J., Kudoh S., Sugisaki K., Oritsu M., Nukiwa T. Epidemiology of Sarcoidosis in Japan. Eur. Respir. J. 2008;31:372–379. doi: 10.1183/09031936.00075307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00075307</ArticleId>
            <ArticleId IdType="pubmed">17959635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jamilloux Y., Maucort-Boulch D., Kerever S., Gerfaud-Valentin M., Broussolle C., Eb M., Valeyre D., Seve P. Sarcoidosis-Related Mortality in France: A Multiple-Cause-of-Death Analysis. Eur. Respir. J. 2016;48:1700–1709. doi: 10.1183/13993003.00457-2016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.00457-2016</ArticleId>
            <ArticleId IdType="pubmed">27660516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baughman R.P., Teirstein A.S., Judson M.A., Rossman M.D., Yeager H., Bresnitz E.A., DePALO L., Hunninghake G., Iannuzzi M.C., Johns C.J., et al.  Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis. Am. J. Respir. Crit. Care Med. 2001;164:1885–1889. doi: 10.1164/ajrccm.164.10.2104046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/ajrccm.164.10.2104046</ArticleId>
            <ArticleId IdType="pubmed">11734441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P., Carmona E.M., Utz J.P., Ryu J.H., Crowson C.S., Matteson E.L. Epidemiology of Sarcoidosis 1946–2013. Mayo Clin. Proc. 2016;91:183–188. doi: 10.1016/j.mayocp.2015.10.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mayocp.2015.10.024</ArticleId>
            <ArticleId IdType="pmc">PMC4744129</ArticleId>
            <ArticleId IdType="pubmed">26727158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mañá J., Rubio-Rivas M., Villalba N., Marcoval J., Iriarte A., Molina-Molina M., Llatjos R., García O., Martínez-Yélamos S., Vicens-Zygmunt V., et al.  Multidisciplinary Approach and Long-Term Follow-up in a Series of 640 Consecutive Patients with Sarcoidosis: Cohort Study of a 40-Year Clinical Experience at a Tertiary Referral Center in Barcelona, Spain. Medicine. 2017;96:e7595. doi: 10.1097/MD.0000000000007595.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000007595</ArticleId>
            <ArticleId IdType="pmc">PMC5521941</ArticleId>
            <ArticleId IdType="pubmed">28723801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valeyre D., Bernaudin J.-F., Jeny F., Duchemann B., Freynet O., Planès C., Kambouchner M., Nunes H. Pulmonary Sarcoidosis. Clin. Chest Med. 2015;36:631–641. doi: 10.1016/j.ccm.2015.08.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccm.2015.08.006</ArticleId>
            <ArticleId IdType="pubmed">26593138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson M.A. The Diagnosis of Sarcoidosis. Clin. Chest Med. 2008;29:415–427. doi: 10.1016/j.ccm.2008.03.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccm.2008.03.009</ArticleId>
            <ArticleId IdType="pubmed">18539235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drent M., Strookappe B., Hoitsma E., De Vries J. Consequences of Sarcoidosis. Clin. Chest Med. 2015;36:727–737. doi: 10.1016/j.ccm.2015.08.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccm.2015.08.013</ArticleId>
            <ArticleId IdType="pubmed">26593145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drent M., Lower E.E., Vries J.D. Sarcoidosis-Associated Fatigue. Eur. Respir. J. 2012;40:255–263. doi: 10.1183/09031936.00002512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00002512</ArticleId>
            <ArticleId IdType="pubmed">22441750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Vries J., Michielsen H., Van Heck G.L., Drent M. Measuring Fatigue in Sarcoidosis: The Fatigue Assessment Scale (FAS) Br. J. Health Psychol. 2004;9:279–291. doi: 10.1348/1359107041557048.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1348/1359107041557048</ArticleId>
            <ArticleId IdType="pubmed">15296678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baughman R.P., Sparkman B.K., Lower E.E. Six-Minute Walk Test and Health Status Assessment in Sarcoidosis. Chest. 2007;132:207–213. doi: 10.1378/chest.06-2822.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.06-2822</ArticleId>
            <ArticleId IdType="pubmed">17625083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drent M., Wirnsberger R.M., de Vries J., van Dieijen-Visser M.P., Wouters E.F.M., Schols A.M.W.J. Association of Fatigue with an Acute Phase Response in Sarcoidosis. Eur. Respir. J. 1999;13:718. doi: 10.1034/j.1399-3003.1999.13d03.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1034/j.1399-3003.1999.13d03.x</ArticleId>
            <ArticleId IdType="pubmed">10362029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korenromp I.H.E., Heijnen C.J., Vogels O.J.M., van den Bosch J.M.M., Grutters J.C. Characterization of Chronic Fatigue in Patients with Sarcoidosis in Clinical Remission. Chest. 2011;140:441–447. doi: 10.1378/chest.10-2629.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.10-2629</ArticleId>
            <ArticleId IdType="pubmed">21330380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michielsen H.J., Drent M., Peros-Golubicic T., De Vries J. Fatigue Is Associated with Quality of Life in Sarcoidosis Patients. Chest. 2006;130:989–994. doi: 10.1378/chest.130.4.989.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.130.4.989</ArticleId>
            <ArticleId IdType="pubmed">17035429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elfferich M.D., Nelemans P.J., Ponds R.W., Vries J.D., Wijnen P.A., Drent M. Everyday Cognitive Failure in Sarcoidosis: The Prevalence and the Effect of Anti-TNF-α Treatment. RES. 2010;80:212–219. doi: 10.1159/000314225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000314225</ArticleId>
            <ArticleId IdType="pubmed">20431280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crouser E.D., Maier L.A., Wilson K.C., Bonham C.A., Morgenthau A.S., Patterson K.C., Abston E., Bernstein R.C., Blankstein R., Chen E.S., et al.  Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am. J. Respir. Crit. Care Med. 2020;201:e26–e51. doi: 10.1164/rccm.202002-0251ST.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.202002-0251ST</ArticleId>
            <ArticleId IdType="pmc">PMC7159433</ArticleId>
            <ArticleId IdType="pubmed">32293205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Telenti A., Hermans P.E. Idiopathic Granulomatosis Manifesting as Fever of Unknown Origin. Mayo Clin. Proc. 1989;64:44–50. doi: 10.1016/S0025-6196(12)65302-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0025-6196(12)65302-6</ArticleId>
            <ArticleId IdType="pubmed">2911215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N. Engl. J. Med. 2007;357:2153–2165. doi: 10.1056/NEJMra071714.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra071714</ArticleId>
            <ArticleId IdType="pubmed">18032765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson M.A., Thompson B.W., Rabin D.L., Steimel J., Knattereud G.L., Lackland D.T., Rose C., Rand C.S., Baughman R.P., Teirstein A.S. The Diagnostic Pathway to Sarcoidosis*. Chest. 2003;123:406–412. doi: 10.1378/chest.123.2.406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.123.2.406</ArticleId>
            <ArticleId IdType="pubmed">12576358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sinha A., Lee K.K., Rafferty G.F., Yousaf N., Pavord I.D., Galloway J., Birring S.S. Predictors of Objective Cough Frequency in Pulmonary Sarcoidosis. Eur. Respir. J. 2016;47:1461–1471. doi: 10.1183/13993003.01369-2015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.01369-2015</ArticleId>
            <ArticleId IdType="pubmed">26846840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeny F., Bernaudin J.-F., Cohen Aubart F., Brillet P.-Y., Bouvry D., Nunes H., Valeyre D. Diagnosis Issues in Sarcoidosis. Respir. Med. Res. 2020;77:37–45. doi: 10.1016/j.resmer.2019.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.resmer.2019.09.002</ArticleId>
            <ArticleId IdType="pubmed">32035337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jameson A., Revels J., Wang L.L., Wang D.T., Wang S.S. Sarcoidosis, the Master Mimicker. Curr. Probl. Diagn. Radiol. 2020:S0363018820301973. doi: 10.1067/j.cpradiol.2020.10.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/j.cpradiol.2020.10.013</ArticleId>
            <ArticleId IdType="pubmed">33308891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venkata Ramanan R., Pudhiavan A., Venkataramanan A. The “Cluster of Black Pearls” Sign of Sarcoid Lymphadenopathy: A New Sign on Thin-Section Contrast-Enhanced Multidetector CT. Clin. Radiol. 2017;72:729–736. doi: 10.1016/j.crad.2017.03.031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.crad.2017.03.031</ArticleId>
            <ArticleId IdType="pubmed">28655404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin S.G., Kronek L.-P., Valeyre D., Brauner N., Brillet P.-Y., Nunes H., Brauner M.W., Réty F. High-Resolution Computed Tomography to Differentiate Chronic Diffuse Interstitial Lung Diseases with Predominant Ground-Glass Pattern Using Logical Analysis of Data. Eur. Radiol. 2010;20:1297–1310. doi: 10.1007/s00330-009-1671-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00330-009-1671-4</ArticleId>
            <ArticleId IdType="pubmed">19997848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valeyre D., Bernaudin J.-F., Uzunhan Y., Kambouchner M., Brillet P.-Y., Soussan M., Nunes H. Clinical Presentation of Sarcoidosis and Diagnostic Work-Up. Semin. Respir. Crit. Care Med. 2014;35:336–351. doi: 10.1055/s-0034-1381229.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0034-1381229</ArticleId>
            <ArticleId IdType="pubmed">25007086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma S.K., Verma U., Pande J.N., Murugesan K., Verma K., Guleria J.S. Glucocorticoid Receptors in Bronchoalveolar Lavage Fluid in Sarcoidosis. Chest. 1988;93:577–579. doi: 10.1378/chest.93.3.577.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.93.3.577</ArticleId>
            <ArticleId IdType="pubmed">3342668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abehsera M., Valeyre D., Grenier P., Jaillet H., Battesti J.P., Brauner M.W. Sarcoidosis with Pulmonary Fibrosis: CT Patterns and Correlation with Pulmonary Function. Am. J. Roentgenol. 2000;174:1751–1757. doi: 10.2214/ajr.174.6.1741751.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/ajr.174.6.1741751</ArticleId>
            <ArticleId IdType="pubmed">10845518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lavergne F., Clerici C., Sadoun D., Brauner M., Battesti J.-P., Valeyre D. Airway Obstruction in Bronchial Sarcoidosis. Chest. 1999;116:1194–1199. doi: 10.1378/chest.116.5.1194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.116.5.1194</ArticleId>
            <ArticleId IdType="pubmed">10559075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chambellan A., Turbie P., Nunes H., Brauner M., Battesti J.-P., Valeyre D. Endoluminal Stenosis of Proximal Bronchi in Sarcoidosis. Chest. 2005;127:472–481. doi: 10.1378/chest.127.2.472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.127.2.472</ArticleId>
            <ArticleId IdType="pubmed">15705984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Udwadia Z.F., Pilling J.R., Jenkins P.F., Harrison B.D. Bronchoscopic and Bronchographic Findings in 12 Patients with Sarcoidosis and Severe or Progressive Airways Obstruction. Thorax. 1990;45:272–275. doi: 10.1136/thx.45.4.272.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/thx.45.4.272</ArticleId>
            <ArticleId IdType="pmc">PMC473771</ArticleId>
            <ArticleId IdType="pubmed">2356554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naccache J.-M., Lavolé A., Nunes H., Lamberto C., Letoumelin P., Brauner M., Valeyre D., Brillet P.Y. High-Resolution Computed Tomographic Imaging of Airways in Sarcoidosis Patients With Airflow Obstruction. J. Comput. Assist. Tomogr. 2008;32:905–912. doi: 10.1097/RCT.0b013e31815b63dd.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/RCT.0b013e31815b63dd</ArticleId>
            <ArticleId IdType="pubmed">19204453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wells A.U., Desai S.R., Rubens M.B., Goh N.S.L., Cramer D., Nicholson A.G., Colby T.V., du Bois R.M., Hansell D.M. Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography. Am. J. Respir. Crit. Care Med. 2003;167:962–969. doi: 10.1164/rccm.2111053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.2111053</ArticleId>
            <ArticleId IdType="pubmed">12663338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walsh S.L., Wells A.U., Sverzellati N., Keir G.J., Calandriello L., Antoniou K.M., Copley S.J., Devaraj A., Maher T.M., Renzoni E., et al.  An Integrated Clinicoradiological Staging System for Pulmonary Sarcoidosis: A Case-Cohort Study. Lancet Respir. Med. 2014;2:123–130. doi: 10.1016/S2213-2600(13)70276-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2213-2600(13)70276-5</ArticleId>
            <ArticleId IdType="pubmed">24503267</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delobbe A., Hélène P., Jocelyne M., Sophie R., Claude H.-F., Benoît W., Bernard A. Impaired Exercise Response in Sarcoid Patients with Normal Pulmonary Function. Sarcoidosis Vasc. Diffus. Lung Dis. 2002;19:148–153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12102611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marcellis R.G.J., Lenssen A.F., de Vries G.J., Baughman R.P., van der Grinten C.P., Verschakelen J.A., De Vries J., Drent M. Is There an Added Value of Cardiopulmonary Exercise Testing in Sarcoidosis Patients? Lung. 2013;191:43–52. doi: 10.1007/s00408-012-9432-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00408-012-9432-6</ArticleId>
            <ArticleId IdType="pubmed">23138855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallaert B., Talleu C., Wemeau-Stervinou L., Duhamel A., Robin S., Aguilaniu B. Reduction of Maximal Oxygen Uptake in Sarcoidosis: Relationship with Disease Severity. Respiration. 2011;82:501–508. doi: 10.1159/000330050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000330050</ArticleId>
            <ArticleId IdType="pubmed">21934275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopes A.J., Menezes S.L.S., Dias C.M., Oliveira J.F., Mainenti M.R.M., Guimarães F.S. Cardiopulmonary Exercise Testing Variables as Predictors of Long-Term Outcome in Thoracic Sarcoidosis. Braz. J. Med. Biol. Res. 2012;45:256–263. doi: 10.1590/S0100-879X2012007500018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0100-879X2012007500018</ArticleId>
            <ArticleId IdType="pmc">PMC3854197</ArticleId>
            <ArticleId IdType="pubmed">22331135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kollert F., Geck B., Suchy R., Jörres R.A., Arzt M., Heidinger D., Hamer O.W., Prasse A., Müller-Quernheim J., Pfeifer M., et al.  The Impact of Gas Exchange Measurement during Exercise in Pulmonary Sarcoidosis. Respir. Med. 2011;105:122–129. doi: 10.1016/j.rmed.2010.09.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2010.09.007</ArticleId>
            <ArticleId IdType="pubmed">20926272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costabel U., Bonella F., Ohshimo S., Guzman J. Diagnostic Modalities in Sarcoidosis: BAL, EBUS, and PET. Semin. Respir. Crit. Care Med. 2010;31:404–408. doi: 10.1055/s-0030-1262207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0030-1262207</ArticleId>
            <ArticleId IdType="pubmed">20665390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darlington P., Kullberg S., Eklund A., Grunewald J. Subpopulations of Cells from Bronchoalveolar Lavage Can Predict Prognosis in Sarcoidosis. Eur. Respir. J. 2020;55:1901450. doi: 10.1183/13993003.01450-2019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.01450-2019</ArticleId>
            <ArticleId IdType="pmc">PMC6991162</ArticleId>
            <ArticleId IdType="pubmed">31439687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mota P.C., Morais A., Palmares C., Beltrão M., Melo N., Santos A.C., Delgado L. Diagnostic Value of CD103 Expression in Bronchoalveolar Lymphocytes in Sarcoidosis. Respir. Med. 2012;106:1014–1020. doi: 10.1016/j.rmed.2012.03.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2012.03.020</ArticleId>
            <ArticleId IdType="pubmed">22537923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heron M., Slieker W.A.T., Zanen P., van Lochem E.G., Hooijkaas H., van den Bosch J.M.M., van Velzen-Blad H. Evaluation of CD103 as a Cellular Marker for the Diagnosis of Pulmonary Sarcoidosis. Clin. Immunol. 2008;126:338–344. doi: 10.1016/j.clim.2007.11.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clim.2007.11.005</ArticleId>
            <ArticleId IdType="pubmed">18182176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boucly A., Weatherald J., Savale L., Jaïs X., Cottin V., Prevot G., Picard F., de Groote P., Jevnikar M., Bergot E., et al.  Risk Assessment, Prognosis and Guideline Implementation in Pulmonary Arterial Hypertension. Eur. Respir. J. 2017;50:1700889. doi: 10.1183/13993003.00889-2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.00889-2017</ArticleId>
            <ArticleId IdType="pubmed">28775050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubio-Rivas M., Franco J., Corbella X. Sarcoidosis Presenting with and without Löfgren’s Syndrome: Clinical, Radiological and Behavioral Differences Observed in a Group of 691 Patients. Jt. Bone Spine. 2020;87:141–147. doi: 10.1016/j.jbspin.2019.10.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jbspin.2019.10.001</ArticleId>
            <ArticleId IdType="pubmed">31606494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karakaya B., Kaiser Y., van Moorsel C., Grunewald J. Löfgren’s Syndrome: Diagnosis, Management, and Disease Pathogenesis. Semin. Respir. Crit. Care Med. 2017;38:463–476. doi: 10.1055/s-0037-1602380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0037-1602380</ArticleId>
            <ArticleId IdType="pubmed">28750461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goussault C., Albert J.-D., Coiffier G., Lamer F., Guillin R., Le Goff B., Bouvard B., Dernis E., Ferreyra M., Cormier G., et al.  Ultrasound Characterization of Ankle Involvement in Löfgren Syndrome. Jt. Bone Spine. 2018;85:65–69. doi: 10.1016/j.jbspin.2017.03.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jbspin.2017.03.004</ArticleId>
            <ArticleId IdType="pubmed">28343011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anandacoomarasamy A., Peduto A., Howe G., Maniolos N., Spencer D. Magnetic Resonance Imaging in Löfgren’s Syndrome: Demonstration of Periarthritis. Clin. Rheumatol. 2006;26:572–575. doi: 10.1007/s10067-006-0360-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-006-0360-9</ArticleId>
            <ArticleId IdType="pubmed">16897117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cacciatore C., Belnou P., Thietart S., Desthieux C., Versini M., Abisror N., Ottaviani S., Cormier G., Deroux A., Dellal A., et al.  Acute and Chronic Sarcoid Arthropathies: Characteristics and Treatments From a Retrospective Nationwide French Study. Front. Med. 2020;7:565420. doi: 10.3389/fmed.2020.565420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmed.2020.565420</ArticleId>
            <ArticleId IdType="pmc">PMC7758528</ArticleId>
            <ArticleId IdType="pubmed">33363181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bechman K., Christidis D., Walsh S., Birring S.S., Galloway J. A Review of the Musculoskeletal Manifestations of Sarcoidosis. Rheumatology. 2018;57:777–783. doi: 10.1093/rheumatology/kex317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/kex317</ArticleId>
            <ArticleId IdType="pubmed">28968840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sweiss N., Patterson K., Sawaqed R., Jabbar U., Korsten P., Hogarth K., Wollman R., Garcia J., Niewold T., Baughman R. Rheumatologic Manifestations of Sarcoidosis. Semin. Respir. Crit. Care Med. 2010;31:463–473. doi: 10.1055/s-0030-1262214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0030-1262214</ArticleId>
            <ArticleId IdType="pmc">PMC3314339</ArticleId>
            <ArticleId IdType="pubmed">20665396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Visser H. Sarcoid Arthritis: Clinical Characteristics, Diagnostic Aspects, and Risk Factors. Ann. Rheum. Dis. 2002;61:499–504. doi: 10.1136/ard.61.6.499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/ard.61.6.499</ArticleId>
            <ArticleId IdType="pmc">PMC1754119</ArticleId>
            <ArticleId IdType="pubmed">12006321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobak S., Sever F., Usluer O., Goksel T., Orman M. The Clinical Characteristics of Sarcoid Arthropathy Based on a Prospective Cohort Study. Ther. Adv. Musculoskelet. Dis. 2016;8:220–224. doi: 10.1177/1759720X16670598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1759720X16670598</ArticleId>
            <ArticleId IdType="pmc">PMC5322860</ArticleId>
            <ArticleId IdType="pubmed">28255335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sukenik S., Hendler N., Yerushalmi B., Buskila D., Liberman N. Jaccoud’s-Type Arthropathy: An Association with Sarcoidosis. J. Rheumatol. 1991;18:915–917.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1895277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erb N., Cushley M.J., Kassimos D.G., Shave R.M., Kitas G.D. An Assessment of Back Pain and the Prevalence of Sacroiliitis in Sarcoidosis. Chest. 2005;127:192–196. doi: 10.1378/chest.127.1.192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.127.1.192</ArticleId>
            <ArticleId IdType="pubmed">15653983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sparks J.A., McSparron J.I., Shah N., Aliabadi P., Paulson V., Fanta C.H., Coblyn J.S. Osseous Sarcoidosis: Clinical Characteristics, Treatment, and Outcomes—Experience from a Large, Academic Hospital. Semin. Arthritis Rheum. 2014;44:371–379. doi: 10.1016/j.semarthrit.2014.07.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semarthrit.2014.07.003</ArticleId>
            <ArticleId IdType="pubmed">25129260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mostard R.L., Prompers L., Weijers R.E., van Kroonenburgh M.J., Wijnen P.A., Geusens P.P., Drent M. F-18 FDG PET/CT for Detecting Bone and Bone Marrow Involvement in Sarcoidosis Patients. Clin. Nucl. Med. 2012;37:21–25. doi: 10.1097/RLU.0b013e3182335f9b.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/RLU.0b013e3182335f9b</ArticleId>
            <ArticleId IdType="pubmed">22157023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rúa-Figueroa I., Gantes M.A., Erausquin C., Mhaidli H., Montesdeoca A. Vertebral Sarcoidosis: Clinical and Imaging Findings. Semin. Arthritis Rheum. 2002;31:346–352. doi: 10.1053/sarh.2002.31553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/sarh.2002.31553</ArticleId>
            <ArticleId IdType="pubmed">11965598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demaria L., Borie R., Benali K., Piekarski E., Goossens G., Palazzo E., Florien M., Dieudé P., Crestani B., Ottaviani S. 18F-FDG PET/CT in Bone Sarcoidosis: An Observational Study. Clin. Rheumatol. 2020;39:2727–2734. doi: 10.1007/s10067-020-05022-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-020-05022-6</ArticleId>
            <ArticleId IdType="pubmed">32198555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berger C., Sommer C., Meinck H.-M. Isolated Sarcoid Myopathy. Muscle Nerve. 2002;26:553–556. doi: 10.1002/mus.10220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mus.10220</ArticleId>
            <ArticleId IdType="pubmed">12362424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Douglas A.C., Macleod J.G., Matthews J.D. Symptomatic Sarcoidosis of Skeletal Muscle. J. Neurol. Neurosurg. Psychiatry. 1973;36:7. doi: 10.1136/jnnp.36.6.1034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp.36.6.1034</ArticleId>
            <ArticleId IdType="pmc">PMC1083605</ArticleId>
            <ArticleId IdType="pubmed">4772718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silverstein A., Siltzbach L.E. Muscle Involvement in Sarcoidosis. Arch. Neurol. 1969;21:7. doi: 10.1001/archneur.1969.00480150025002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneur.1969.00480150025002</ArticleId>
            <ArticleId IdType="pubmed">5802453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfe S.M., Pinals R.S., Aelion J.A., Goodman R.E. Myopathy in Sarcoidosis: Clinical and Pathologic Study of Four Cases and Review of the Literature. Semin. Arthritis Rheum. 1987;16:300–306. doi: 10.1016/0049-0172(87)90008-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0049-0172(87)90008-4</ArticleId>
            <ArticleId IdType="pubmed">3299715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cremers J.P., Van Kroonenburgh M.J., Mostard R.L., Vöö S.A., Wijnen P.A., Koek G.H., Drent M. Extent of Disease Activity Assessed by 18F-FDG PET/CT in a Dutch Sarcoidosis Population. Sarcoidosis Vasc. Diffus. Lung Dis. 2014;31:37–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24751452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roux K.L., Streichenberger N., Vial C., Petiot P., Feasson L., Bouhour F., Ninet J., Lachenal F., Broussolle C., Sève P. Granulomatous Myositis: A Clinical Study of Thirteen Cases. Muscle Nerve. 2007;35:171–177. doi: 10.1002/mus.20683.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mus.20683</ArticleId>
            <ArticleId IdType="pubmed">17068767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Androdias G., Maillet D., Marignier R., Pinede L., Confavreux C., Broussolle C., Vukusic S., Seve P. Mycophenolate Mofetil May Be Effective in CNS Sarcoidosis but Not in Sarcoid Myopathy. Neurology. 2011;76:1168–1172. doi: 10.1212/WNL.0b013e318212aafb.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0b013e318212aafb</ArticleId>
            <ArticleId IdType="pubmed">21444902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dieudonné Y., Allenbach Y., Benveniste O., Leonard-Louis S., Hervier B., Mariampillai K., Nespola B., Lannes B., Echaniz-Laguna A., Wendling D., et al.  Granulomatosis-Associated Myositis: High Prevalence of Sporadic Inclusion Body Myositis. Neurology. 2020;94:e910–e920. doi: 10.1212/WNL.0000000000008863.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000008863</ArticleId>
            <ArticleId IdType="pubmed">31882529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P., Crowson C.S., Matteson E.L. Influence of Gender on Epidemiology and Clinical Manifestations of Sarcoidosis: A Population-Based Retrospective Cohort Study 1976-2013. Lung. 2017;195:87–91. doi: 10.1007/s00408-016-9952-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00408-016-9952-6</ArticleId>
            <ArticleId IdType="pmc">PMC5291820</ArticleId>
            <ArticleId IdType="pubmed">27709291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>James D.G., Neville E., Siltzbach L.E., Turiaf J., Battesti J.P., Sharma O.P., Hosoda Y., Mikami R., Odaka M., Villar T.G., et al.  A Worldwide Review of Sarcoidosis*. Ann. N. Y. Acad. Sci. 1976;278:321–334. doi: 10.1111/j.1749-6632.1976.tb47043.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1749-6632.1976.tb47043.x</ArticleId>
            <ArticleId IdType="pubmed">1067017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Studdy P.R., Bird R., Neville E., James D.G. Biochemical Findings in Sarcoidosis. J. Clin. Pathol. 1980;33:528–533. doi: 10.1136/jcp.33.6.528.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jcp.33.6.528</ArticleId>
            <ArticleId IdType="pmc">PMC1146136</ArticleId>
            <ArticleId IdType="pubmed">6249857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baughman R.P., Janovcik J., Ray M., Sweiss N., Lower E.E. Calcium and Vitamin D Metabolism in Sarcoidosis. Sarcoidosis Vasc. Diffus. Lung Dis. 2013;30:113–120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24071882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gwadera Ł., Białas A.J., Iwański M.A., Górski P., Piotrowski W.J. Sarcoidosis and Calcium Homeostasis Disturbances—Do We Know Where We Stand? Chron. Respir. Dis. 2019;16 doi: 10.1177/1479973119878713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1479973119878713</ArticleId>
            <ArticleId IdType="pmc">PMC6854763</ArticleId>
            <ArticleId IdType="pubmed">31718265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adams J.S. Vitamin D Metabolite-Mediated Hypercalcemia. Endocrinol. Metab. Clin. N. Am. 1989;18:765–778. doi: 10.1016/S0889-8529(18)30365-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0889-8529(18)30365-7</ArticleId>
            <ArticleId IdType="pubmed">2673772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caplan A., Rosenbach M., Imadojemu S. Cutaneous Sarcoidosis. Semin. Respir. Crit. Care Med. 2020;41:689–699. doi: 10.1055/s-0040-1713130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0040-1713130</ArticleId>
            <ArticleId IdType="pubmed">32593176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marcoval J., Mañá J., Rubio M. Specific Cutaneous Lesions in Patients with Systemic Sarcoidosis: Relationship to Severity and Chronicity of Disease. Clin. Exp. Dermatol. 2011;36:739–744. doi: 10.1111/j.1365-2230.2011.04128.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2230.2011.04128.x</ArticleId>
            <ArticleId IdType="pubmed">21790725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haimovic A., Sanchez M., Judson M.A., Prystowsky S. Sarcoidosis: A Comprehensive Review and Update for the Dermatologist. J. Am. Acad. Dermatol. 2012;66:719.e1–719.e10. doi: 10.1016/j.jaad.2012.02.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaad.2012.02.003</ArticleId>
            <ArticleId IdType="pubmed">22507586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bodaghi B., Touitou V., Fardeau C., Chapelon C., LeHoang P. Ocular Sarcoidosis. La Presse Médicale. 2012;41:e349–e354. doi: 10.1016/j.lpm.2012.04.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lpm.2012.04.004</ArticleId>
            <ArticleId IdType="pubmed">22595776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jamilloux Y., Kodjikian L., Broussolle C., Sève P. Sarcoidosis and Uveitis. Autoimmun. Rev. 2014;13:840–849. doi: 10.1016/j.autrev.2014.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.autrev.2014.04.001</ArticleId>
            <ArticleId IdType="pubmed">24704868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coulon C., Kodjikian L., Rochepeau C., Perard L., Jardel S., Burillon C., Broussolle C., Jamilloux Y., Seve P. Ethnicity and Association with Ocular, Systemic Manifestations and Prognosis in 194 Patients with Sarcoid Uveitis. Graefes Arch. Clin. Exp. Ophthalmol. 2019;257:2495–2503. doi: 10.1007/s00417-019-04415-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00417-019-04415-x</ArticleId>
            <ArticleId IdType="pubmed">31302765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birnbaum A.D., French D.D., Mirsaeidi M., Wehrli S. Sarcoidosis in the National Veteran Population. Ophthalmology. 2015;122:934–938. doi: 10.1016/j.ophtha.2015.01.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ophtha.2015.01.003</ArticleId>
            <ArticleId IdType="pmc">PMC4414801</ArticleId>
            <ArticleId IdType="pubmed">25687027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasadhika S., Rosenbaum J.T. Ocular Sarcoidosis. Clin. Chest Med. 2015;36:669–683. doi: 10.1016/j.ccm.2015.08.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccm.2015.08.009</ArticleId>
            <ArticleId IdType="pmc">PMC4662043</ArticleId>
            <ArticleId IdType="pubmed">26593141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma S.P., Rogers S.L., Hall A.J., Hodgson L., Brennan J., Stawell R.J., Lim L.L. Sarcoidosis-Related Uveitis: Clinical Presentation, Disease Course, and Rates of Systemic Disease Progression After Uveitis Diagnosis. Am. J. Ophthalmol. 2019;198:30–36. doi: 10.1016/j.ajo.2018.09.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajo.2018.09.013</ArticleId>
            <ArticleId IdType="pubmed">30243930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greenberg G., Anderson R., Sharpstone P., James D.G. Enlargement of Parotid Gland Due to Sarcoidosis. Br. Med. J. 1964;2:861–862. doi: 10.1136/bmj.2.5413.861.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.2.5413.861</ArticleId>
            <ArticleId IdType="pmc">PMC1816279</ArticleId>
            <ArticleId IdType="pubmed">14185639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darlington P., Tallstedt L., Padyukov L., Kockum I., Cederlund K., Eklund A., Grunewald J. HLA-DRB1* Alleles and Symptoms Associated with Heerfordt’s Syndrome in Sarcoidosis. Eur. Respir. J. 2011 doi: 10.1183/09031936.00025011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00025011</ArticleId>
            <ArticleId IdType="pubmed">21565911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heerfordt C. Über Eine ‘Febris Uveoparotidea Subchronica’ an Der Glandula Parotis Der Uvea Des Auges Lokalisiert Und Häufig Mit Paresen Cerebrospinaler Nerver Kompliziert. Arch. Ophthalmol. 1909;70:254–273.</Citation>
        </Reference>
        <Reference>
          <Citation>Makimoto G., Kawakado K., Nakanishi M., Tamura T., Noda M., Makimoto S., Sato Y., Kuyama S. Heerfordt’s Syndrome Associated with Trigeminal Nerve Palsy and Reversed Halo Sign. Intern. Med. 2020 doi: 10.2169/internalmedicine.6176-20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2169/internalmedicine.6176-20</ArticleId>
            <ArticleId IdType="pubmed">33390492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mikulic S., Patel P., Sheffield S., Kandah F., Velarde G. Heerfordt-Waldenström Syndrome Manifesting as Cardiac Sarcoidosis. Cureus. 2020;12:e10619. doi: 10.7759/cureus.10619.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.10619</ArticleId>
            <ArticleId IdType="pmc">PMC7515795</ArticleId>
            <ArticleId IdType="pubmed">32983747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rochepeau C., Jamilloux Y., Kerever S., Febvay C., Perard L., Broussolle C., Burillon C., Kodjikian L., Seve P. Long-Term Visual and Systemic Prognoses of 83 Cases of Biopsy-Proven Sarcoid Uveitis. Br. J. Ophthalmol. 2017;101:856–861. doi: 10.1136/bjophthalmol-2016-309767.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjophthalmol-2016-309767</ArticleId>
            <ArticleId IdType="pubmed">27888183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sève P., Jamilloux Y., Tilikete C., Gerfaud-Valentin M., Kodjikian L., El Jammal T. Ocular Sarcoidosis. Semin. Respir. Crit. Care Med. 2020;41:673–688. doi: 10.1055/s-0040-1710536.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0040-1710536</ArticleId>
            <ArticleId IdType="pubmed">32777852</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paovic J., Paovic P., Sredovic V., Jovanovic S. Clinical Manifestations, Complications and Treatment of Ocular Sarcoidosis: Correlation between Visual Efficiency and Macular Edema as Seen on Optical Coherence Tomography. Semin. Ophthalmol. 2016:1–8. doi: 10.1080/08820538.2016.1206576.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/08820538.2016.1206576</ArticleId>
            <ArticleId IdType="pubmed">27628176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miserocchi E., Modorati G., Di Matteo F., Galli L., Rama P., Bandello F. Visual Outcome in Ocular Sarcoidosis: Retrospective Evaluation of Risk Factors. Eur. J. Ophthalmol. 2011;21:802–810. doi: 10.5301/EJO.2011.6417.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5301/EJO.2011.6417</ArticleId>
            <ArticleId IdType="pubmed">21374555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dana M.-R., Merayo-Lloves J., Schaumberg D.A., Foster C.S. Prognosticators for Visual Outcome in Sarcoid Uveitis. Ophthalmology. 1996;103:1846–1853. doi: 10.1016/S0161-6420(96)30417-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0161-6420(96)30417-X</ArticleId>
            <ArticleId IdType="pubmed">8942880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rothova A. Ocular Involvement in Sarcoidosis. Br. J. Ophthalmol. 2000;84:110–116. doi: 10.1136/bjo.84.1.110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjo.84.1.110</ArticleId>
            <ArticleId IdType="pmc">PMC1723211</ArticleId>
            <ArticleId IdType="pubmed">10611110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koczman J.J., Rouleau J., Gaunt M., Kardon R.H., Wall M., Lee A.G. Neuro-Ophthalmic Sarcoidosis: The University of Iowa Experience. Semin. Ophthalmol. 2008;23:157–168. doi: 10.1080/08820530802007382.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/08820530802007382</ArticleId>
            <ArticleId IdType="pubmed">18432542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prabhakaran V.C., Saeed P., Esmaeli B., Sullivan T.J., McNab A., Davis G., Valenzuela A., Leibovitch I., Kesler A., Sivak-Callcott J., et al.  Orbital and Adnexal Sarcoidosis. Arch. Ophthalmol. 2007;125:1657–1662. doi: 10.1001/archopht.125.12.1657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archopht.125.12.1657</ArticleId>
            <ArticleId IdType="pubmed">18071118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braswell R.A., Kline L.B. Neuro-Ophthalmologic Manifestations of Sarcoidosis. Int. Ophthalmol. Clin. 2007;47:67–77. doi: 10.1097/IIO.0b013e3181571d65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/IIO.0b013e3181571d65</ArticleId>
            <ArticleId IdType="pubmed">18049281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leclercq M., Langlois V., Girszyn N., Le Besnerais M., Benhamou Y., Levesque H., Muraine M., Gueudry J. Comparison of Conventional Immunosuppressive Drugs versus Anti-TNF-α Agents in Non-Infectious Non-Anterior Uveitis. J. Autoimmun. 2020;113:102481. doi: 10.1016/j.jaut.2020.102481.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaut.2020.102481</ArticleId>
            <ArticleId IdType="pubmed">32586650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tadros M., Forouhar F., Wu G.Y. Hepatic Sarcoidosis. J. Clin. Transl. Hepatol. 2013;1:87–93. doi: 10.14218/JCTH.2013.00016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14218/JCTH.2013.00016</ArticleId>
            <ArticleId IdType="pmc">PMC4521279</ArticleId>
            <ArticleId IdType="pubmed">26357609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deutsch-Link S., Fortuna D., Weinberg E.M. A Comprehensive Review of Hepatic Sarcoid. Semin. Liver Dis. 2018;38:284–297. doi: 10.1055/s-0038-1666853.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0038-1666853</ArticleId>
            <ArticleId IdType="pubmed">30041280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson M. Extrapulmonary Sarcoidosis. Semin. Respir. Crit. Care Med. 2007;28:083–101. doi: 10.1055/s-2007-970335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-2007-970335</ArticleId>
            <ArticleId IdType="pubmed">17330194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bihari C., Rastogi A., Kumar N., Rajesh S., Sarin S.K. Hepatic Sarcoidosis: Clinico-Pathological Characterization of Symptomatic Cases. Acta Gastroenterol. Belg. 2015;78:306–313.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26448412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moreno-Merlo F., Wanless I.R., Shimamatsu K., Sherman M., Greig P., Chiasson D. The Role of Granulomatous Phlebitis and Thrombosis in the Pathogenesis of Cirrhosis and Portal Hypertension in Sarcoidosis. Hepatology. 1997;26:554–560. doi: 10.1002/hep.510260304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.510260304</ArticleId>
            <ArticleId IdType="pubmed">9303482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alam I., Levenson S.D., Ferrell L.D., Bass N.M. Diffuse Intrahepatic Biliary Strictures in Sarcoidosis Resembling Sclerosing Cholangitis (Case Report and Review of the Literature) Dig. Dis. Sci. 1997;42:1295–1301. doi: 10.1023/A:1018874612166.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1018874612166</ArticleId>
            <ArticleId IdType="pubmed">9201098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delfosse V., de Leval L., De Roover A., Delwaide J., Honoré P., Boniver J., Detry O. Budd-Chiari Syndrome Complicating Hepatic Sarcoidosis: Definitive Treatment by Liver Transplantation: A Case Report. Transplant. Proc. 2009;41:3432–3434. doi: 10.1016/j.transproceed.2009.09.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.transproceed.2009.09.021</ArticleId>
            <ArticleId IdType="pubmed">19857764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P., Crowson C.S., Simonetto D.A., Matteson E.L. Clinical Characteristics and Outcome of Hepatic Sarcoidosis: A Population-Based Study 1976–2013. Am. J. Gastroenterol. 2017;112:1556–1563. doi: 10.1038/ajg.2017.231.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ajg.2017.231</ArticleId>
            <ArticleId IdType="pmc">PMC5629110</ArticleId>
            <ArticleId IdType="pubmed">28872150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warshauer D.M., Dumbleton S.A., Molina P.L., Yankaskas B.C., Parker L.A., Woosley J.T. Abdominal CT Findings in Sarcoidosis: Radiologic and Clinical Correlation. Radiology. 1994;192:93–98. doi: 10.1148/radiology.192.1.8208972.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiology.192.1.8208972</ArticleId>
            <ArticleId IdType="pubmed">8208972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P., Ryu J.H., Matteson E.L. Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis. Mayo Clin. Proc. Innov. Qual. Outcomes. 2019;3:358–375. doi: 10.1016/j.mayocpiqo.2019.04.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mayocpiqo.2019.04.006</ArticleId>
            <ArticleId IdType="pmc">PMC6713839</ArticleId>
            <ArticleId IdType="pubmed">31485575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Syed U., Alkhawam H., Bakhit M., Companioni R.A.C., Walfish A. Hepatic Sarcoidosis: Pathogenesis, Clinical Context, and Treatment Options. Scand. J. Gastroenterol. 2016;51:1025–1030. doi: 10.1080/00365521.2016.1177856.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00365521.2016.1177856</ArticleId>
            <ArticleId IdType="pubmed">27175775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coash M., Forouhar F., Wu C.H., Wu G.Y. Granulomatous Liver Diseases: A Review. J. Formos. Med. Assoc. 2012;111:3–13. doi: 10.1016/j.jfma.2011.11.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jfma.2011.11.023</ArticleId>
            <ArticleId IdType="pubmed">22333006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lagana S.M., Moreira R.K., Lefkowitch J.H. Hepatic Granulomas: Pathogenesis and Differential Diagnosis. Clin. Liver Dis. 2010;14:605–617. doi: 10.1016/j.cld.2010.07.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cld.2010.07.005</ArticleId>
            <ArticleId IdType="pubmed">21055685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaya D.R. Hepatic Granulomas: A 10 Year Single Centre Experience. J. Clin. Pathol. 2003;56:850–853. doi: 10.1136/jcp.56.11.850.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jcp.56.11.850</ArticleId>
            <ArticleId IdType="pmc">PMC1770104</ArticleId>
            <ArticleId IdType="pubmed">14600131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geri G., Cacoub P. Granulomatose hépatique. Rev. Méd. Interne. 2011;32:560–566. doi: 10.1016/j.revmed.2010.06.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.revmed.2010.06.017</ArticleId>
            <ArticleId IdType="pubmed">20832918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wainwright H. Hepatic Granulomas. Eur. J. Gastroenterol. Hepatol. 2007;19:93–95. doi: 10.1097/MEG.0b013e3280115523.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MEG.0b013e3280115523</ArticleId>
            <ArticleId IdType="pubmed">17272991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Esfeh J.M., Culver D., Plesec T., John B. Clinical Presentation and Protocol for Management of Hepatic Sarcoidosis. Expert Rev. Gastroenterol. Hepatol. 2015;9:349–358. doi: 10.1586/17474124.2015.958468.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/17474124.2015.958468</ArticleId>
            <ArticleId IdType="pubmed">25473783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Britt A.R., Francis I.R., Glazer G.M., Ellis J.H. Sarcoidosis: Abdominal Manifestations at CT. Radiology. 1991;178:91–94. doi: 10.1148/radiology.178.1.1984330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiology.178.1.1984330</ArticleId>
            <ArticleId IdType="pubmed">1984330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Folz S.J., Johnson C.D., Swensen S.J. Abdominal Manifestations of Sarcoidosis in CT Studies. J. Comput. Assist. Tomogr. 1995;19:573–579. doi: 10.1097/00004728-199507000-00013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00004728-199507000-00013</ArticleId>
            <ArticleId IdType="pubmed">7622687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warshauer D.M., Molina P.L., Hamman S.M., Koehler R.E., Paulson E.K., Bechtold R.E., Perlmutter M.L., Hiken J.N., Francis I.R., Cooper C.J. Nodular Sarcoidosis of the Liver and Spleen: Analysis of 32 Cases. Radiology. 1995;195:757–762. doi: 10.1148/radiology.195.3.7754007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiology.195.3.7754007</ArticleId>
            <ArticleId IdType="pubmed">7754007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tetikkurt C., Yanardag H., Pehlivan M., Bilir M. Clinical Features and Prognostic Significance of Splenic Involvement in Sarcoidosis. Monaldi Arch. Chest Dis. 2017;87 doi: 10.4081/monaldi.2017.893.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4081/monaldi.2017.893</ArticleId>
            <ArticleId IdType="pubmed">29424195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Warshauer D.M., Lee J.K.T. Imaging Manifestations of Abdominal Sarcoidosis. Am. J. Roentgenol. 2004;182:15–28. doi: 10.2214/ajr.182.1.1820015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/ajr.182.1.1820015</ArticleId>
            <ArticleId IdType="pubmed">14684507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tana C., Donatiello I., Coppola M.G., Ricci F., Maccarone M.T., Ciarambino T., Cipollone F., Giamberardino M.A. CT Findings in Pulmonary and Abdominal Sarcoidosis. Implications for Diagnosis and Classification. J. Clin. Med. 2020;9:3028.  doi: 10.3390/jcm9093028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9093028</ArticleId>
            <ArticleId IdType="pmc">PMC7565100</ArticleId>
            <ArticleId IdType="pubmed">32962242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghrenassia E., Mekinian A., Chapelon-Albric C., Levy P., Cosnes J., Sève P., Lefèvre G., Dhôte R., Launay D., Prendki V., et al.  Digestive-Tract Sarcoidosis: French Nationwide Case-Control Study of 25 Cases. Medicine. 2016;95:e4279. doi: 10.1097/MD.0000000000004279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000004279</ArticleId>
            <ArticleId IdType="pmc">PMC5265782</ArticleId>
            <ArticleId IdType="pubmed">27442665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munker M., Sharma O.P. Fatal Gastrointestinal Haemorrhage in Sarcoidosis: A Previously Unreported Occurrence. Sarcoidosis. 1987;4:55–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3495838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inomata M., Ikushima S., Awano N., Kondoh K., Satake K., Masuo M., Moriya A., Kamiya H., Ando T., Azuma A., et al.  Upper Gastrointestinal Sarcoidosis: Report of Three Cases. Intern. Med. 2012;51:1689–1694. doi: 10.2169/internalmedicine.51.7367.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2169/internalmedicine.51.7367</ArticleId>
            <ArticleId IdType="pubmed">22790127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubio-Rivas M., Corbella X. Clinical Phenotypes and Prediction of Chronicity in Sarcoidosis Using Cluster Analysis in a Prospective Cohort of 694 Patients. Eur. J. Intern. Med. 2020;77:59–65. doi: 10.1016/j.ejim.2020.04.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejim.2020.04.024</ArticleId>
            <ArticleId IdType="pubmed">32331839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schupp J.C., Freitag-Wolf S., Bargagli E., Mihailović-Vučinić V., Rottoli P., Grubanovic A., Müller A., Jochens A., Tittmann L., Schnerch J., et al.  Phenotypes of Organ Involvement in Sarcoidosis. Eur. Respir. J. 2018;51:1700991. doi: 10.1183/13993003.00991-2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.00991-2017</ArticleId>
            <ArticleId IdType="pubmed">29371378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chapelon-Abric C., De Zuttere D., Duhaut P., Veyssier P., Wechsler B., Huong D.L.T., De Gennes C., Papo T., Blétry O., Godeau P., et al.  Cardiac Sarcoidosis: A Retrospective Study of 41 Cases. Medicine. 2004;83:315–334. doi: 10.1097/01.md.0000145367.17934.75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.md.0000145367.17934.75</ArticleId>
            <ArticleId IdType="pubmed">15525844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han Y.S., Rivera-Grana E., Salek S., Rosenbaum J.T. Distinguishing Uveitis Secondary to Sarcoidosis From Idiopathic Disease: Cardiac Implications. Jama Ophthalmol. 2018;136:109. doi: 10.1001/jamaophthalmol.2017.5466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaophthalmol.2017.5466</ArticleId>
            <ArticleId IdType="pmc">PMC5838604</ArticleId>
            <ArticleId IdType="pubmed">29327057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birnie D.H., Sauer W.H., Bogun F., Cooper J.M., Culver D.A., Duvernoy C.S., Judson M.A., Kron J., Mehta D., Cosedis Nielsen J., et al.  HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated with Cardiac Sarcoidosis. Heart Rhythm. 2014;11:1304–1323. doi: 10.1016/j.hrthm.2014.03.043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.hrthm.2014.03.043</ArticleId>
            <ArticleId IdType="pubmed">24819193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehta D., Lubitz S.A., Frankel Z., Wisnivesky J.P., Einstein A.J., Goldman M., Machac J., Teirstein A. Cardiac Involvement in Patients with Sarcoidosis: Diagnostic and Prognostic Value of Outpatient Testing. Chest. 2008;133:1426–1435. doi: 10.1378/chest.07-2784.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.07-2784</ArticleId>
            <ArticleId IdType="pubmed">18339784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kouranos V., Tzelepis G.E., Rapti A., Mavrogeni S., Aggeli K., Douskou M., Prasad S., Koulouris N., Sfikakis P., Wells A., et al.  Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis. JACC Cardiovasc. Imaging. 2017;10:1437–1447. doi: 10.1016/j.jcmg.2016.11.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcmg.2016.11.019</ArticleId>
            <ArticleId IdType="pubmed">28330653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silverman K.J., Hutchins G.M., Bulkley B.H. Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis. Circulation. 1978;58:1204–1211. doi: 10.1161/01.CIR.58.6.1204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.58.6.1204</ArticleId>
            <ArticleId IdType="pubmed">709777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwai K., Tachibana T., Takemura T., Matsui Y., Kitalchi M., Kawabata Y. Pathological Studies on Sarcoidosis Autopsy. I. Epidemiological Features of 320 Cases in Japan. Pathol. Int. 1993;43:372–376. doi: 10.1111/j.1440-1827.1993.tb01148.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1827.1993.tb01148.x</ArticleId>
            <ArticleId IdType="pubmed">8372682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nunes H., Freynet O., Naggara N., Soussan M., Weinman P., Diebold B., Brillet P.-Y., Valeyre D. Cardiac Sarcoidosis. Semin. Respir. Crit. Care Med. 2010;31:428–441. doi: 10.1055/s-0030-1262211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0030-1262211</ArticleId>
            <ArticleId IdType="pubmed">20665393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kandolin R., Lehtonen J., Airaksinen J., Vihinen T., Miettinen H., Ylitalo K., Kaikkonen K., Tuohinen S., Haataja P., Kerola T., et al.  Cardiac Sarcoidosis: Epidemiology, Characteristics, and Outcome over 25 Years in a Nationwide Study. Circulation. 2015;131:624–632. doi: 10.1161/CIRCULATIONAHA.114.011522.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.011522</ArticleId>
            <ArticleId IdType="pubmed">25527698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ribeiro Neto M.L., Jellis C.L., Joyce E., Callahan T.D., Hachamovitch R., Culver D.A. Update on Cardiac Sarcoidosis. Ann. Am. Thorac. Soc. 2019 doi: 10.1513/AnnalsATS.201902-119CME.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1513/AnnalsATS.201902-119CME</ArticleId>
            <ArticleId IdType="pubmed">31322914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Y., Lower E.E., Li H.-P., Costea A., Attari M., Baughman R.P. Cardiac Sarcoidosis: The Impact of Age and Implanted Devices on Survival. Chest. 2017;151:139–148. doi: 10.1016/j.chest.2016.08.1457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2016.08.1457</ArticleId>
            <ArticleId IdType="pubmed">27614001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurmann R. Echocardiography in Sarcoidosis. Curr. Cardiol. Rep. 2018;20:118. doi: 10.1007/s11886-018-1065-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11886-018-1065-9</ArticleId>
            <ArticleId IdType="pubmed">30259211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terasaki F., Yoshinaga K. New Guidelines for Diagnosis of Cardiac Sarcoidosis in Japan. Ann. Nucl. Cardiol. 2017;3:42–45. doi: 10.17996/anc.17-00042.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.17996/anc.17-00042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murtagh G., Laffin L.J., Beshai J.F., Maffessanti F., Bonham C.A., Patel V.A., Yu Z., Addetia K., Mor-Avi V., Moss J.D., et al.  Prognosis of Myocardial Damage in Sarcoidosis Patients with Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance. Circ. Cardiovasc. Imaging. 2016;9:1–9. doi: 10.1161/CIRCIMAGING.115.003738.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCIMAGING.115.003738</ArticleId>
            <ArticleId IdType="pmc">PMC4718184</ArticleId>
            <ArticleId IdType="pubmed">26763280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hulten E., Agarwal V., Cahill M., Cole G., Vita T., Parrish S., Bittencourt M.S., Murthy V.L., Kwong R., Di Carli M.F., et al.  Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis. Circ. Cardiovasc. Imaging. 2016;9:139–148. doi: 10.1161/CIRCIMAGING.116.005001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCIMAGING.116.005001</ArticleId>
            <ArticleId IdType="pmc">PMC5449111</ArticleId>
            <ArticleId IdType="pubmed">27621357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nadel J., Lancefield T., Voskoboinik A., Taylor A.J. Late Gadolinium Enhancement Identified with Cardiacmagnetic Resonance Imaging in Sarcoidosis Patients Is Associated with Long-Term Ventricular Arrhythmia and Sudden Cardiac Death. Eur. Heart J. Cardiovasc. Imaging. 2015;16:634–641. doi: 10.1093/ehjci/jeu294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ehjci/jeu294</ArticleId>
            <ArticleId IdType="pubmed">25617029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shafee M.A., Fukuda K., Wakayama Y., Nakano M., Kondo M., Hasebe Y., Kawana A., Shimokawa H. Delayed Enhancement on Cardiac Magnetic Resonance Imaging Is a Poor Prognostic Factor in Patients with Cardiac Sarcoidosis. J. Cardiol. 2012;60:448–453. doi: 10.1016/j.jjcc.2012.08.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jjcc.2012.08.002</ArticleId>
            <ArticleId IdType="pubmed">22944174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vita T., Okada D.R., Veillet-Chowdhury M., Bravo P.E., Mullins E., Hulten E., Agrawal M., Madan R., Taqueti V.R., Steigner M., et al.  Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Circ. Cardiovasc. Imaging. 2018;11:e007030. doi: 10.1161/CIRCIMAGING.117.007030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCIMAGING.117.007030</ArticleId>
            <ArticleId IdType="pmc">PMC6381829</ArticleId>
            <ArticleId IdType="pubmed">29335272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birnie D., Beanlands R.S.B., Nery P., Aaron S.D., Culver D.A., DeKemp R.A., Gula L., Ha A., Healey J.S., Inoue Y., et al.  Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial (CHASM CS- RCT) Am. Heart J. 2020;220:246–252. doi: 10.1016/j.ahj.2019.10.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ahj.2019.10.003</ArticleId>
            <ArticleId IdType="pmc">PMC7367280</ArticleId>
            <ArticleId IdType="pubmed">31911261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ardehali H., Howard D.L., Hariri A., Qasim A., Hare J.M., Baughman K.L., Kasper E.K. A Positive Endomyocardial Biopsy Result for Sarcoid Is Associated with Poor Prognosis in Patients with Initially Unexplained Cardiomyopathy. Am. Heart J. 2005;150:459–463. doi: 10.1016/j.ahj.2004.10.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ahj.2004.10.006</ArticleId>
            <ArticleId IdType="pubmed">16169324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fritz D., van de Beek D., Brouwer M.C. Clinical Features, Treatment and Outcome in Neurosarcoidosis: Systematic Review and Meta-Analysis. BMC Neurol. 2016;16:220.  doi: 10.1186/s12883-016-0741-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12883-016-0741-x</ArticleId>
            <ArticleId IdType="pmc">PMC5109654</ArticleId>
            <ArticleId IdType="pubmed">27846819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cação G., Branco A., Meireles M., Alves J.E., Mateus A., Silva A.M., Santos E. Neurosarcoidosis According to Zajicek and Scolding Criteria: 15 Probable and Definite Cases, Their Treatment and Outcomes. J. Neurol. Sci. 2017;379:84–88. doi: 10.1016/j.jns.2017.05.055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2017.05.055</ArticleId>
            <ArticleId IdType="pubmed">28716286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kidd D.P. Neurosarcoidosis: Clinical Manifestations, Investigation and Treatment. Pract. Neurol. 2020;20:199–212. doi: 10.1136/practneurol-2019-002349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/practneurol-2019-002349</ArticleId>
            <ArticleId IdType="pubmed">32424017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P., Crowson C.S., Matteson E.L. Characteristics and Long-Term Outcome of Neurosarcoidosis: A Population-Based Study from 1976-2013. Neuroepidemiology. 2017;48:87–94. doi: 10.1159/000477300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000477300</ArticleId>
            <ArticleId IdType="pmc">PMC5575952</ArticleId>
            <ArticleId IdType="pubmed">28601860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ungprasert P., Matteson E.L. Neurosarcoidosis. Rheum. Dis. Clin. N. Am. 2017;43:593–606. doi: 10.1016/j.rdc.2017.06.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rdc.2017.06.008</ArticleId>
            <ArticleId IdType="pubmed">29061245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Culver D.A., Neto M.L.R., Moss B.P., Willis M.A. Neurosarcoidosis. Semin. Respir. Crit. Care Med. 2017;38:499–513. doi: 10.1055/s-0037-1604165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0037-1604165</ArticleId>
            <ArticleId IdType="pubmed">28750463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joubert B., Chapelon-Abric C., Biard L., Saadoun D., Demeret S., Dormont D., Resche-Rigon M., Cacoub P. Association of Prognostic Factors and Immunosuppressive Treatment With Long-Term Outcomes in Neurosarcoidosis. JAMA Neurol. 2017;74:1336–1344. doi: 10.1001/jamaneurol.2017.2492.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaneurol.2017.2492</ArticleId>
            <ArticleId IdType="pmc">PMC5710577</ArticleId>
            <ArticleId IdType="pubmed">29052709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bridel C., Courvoisier D.S., Vuilleumier N., Lalive P.H. Cerebrospinal Fluid Angiotensin-Converting Enzyme for Diagnosis of Neurosarcoidosis. J. Neuroimmunol. 2015;285:1–3. doi: 10.1016/j.jneuroim.2015.05.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2015.05.020</ArticleId>
            <ArticleId IdType="pubmed">26198911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arun T., Pattison L., Palace J. Distinguishing Neurosarcoidosis from Multiple Sclerosis Based on CSF Analysis: A Retrospective Study. Neurology. 2020;94:e2545–e2554. doi: 10.1212/WNL.0000000000009491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000009491</ArticleId>
            <ArticleId IdType="pubmed">32354749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chazal T., Costopoulos M., Maillart E., Fleury C., Psimaras D., Legendre P., Pineton de Chambrun M., Haroche J., Lubetzki C., Amoura Z., et al.  The Cerebrospinal Fluid CD4/CD8 Ratio and Interleukin-6 and -10 Levels in Neurosarcoidosis: A Multicenter, Pragmatic, Comparative Study. Eur. J. Neurol. 2019;26:1274–1280. doi: 10.1111/ene.13975.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.13975</ArticleId>
            <ArticleId IdType="pubmed">31021023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stern B.J., Aksamit A., Clifford D., Scott T.F. Neurosarcoidosis Study Group Neurologic Presentations of Sarcoidosis. Neurol. Clin. 2010;28:185–198. doi: 10.1016/j.ncl.2009.09.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ncl.2009.09.012</ArticleId>
            <ArticleId IdType="pubmed">19932381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scott T.F., Yandora K., Valeri A., Chieffe C., Schramke C. Aggressive Therapy for Neurosarcoidosis: Long-Term Follow-up of 48 Treated Patients. Arch. Neurol. 2007;64:691–696. doi: 10.1001/archneur.64.5.691.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneur.64.5.691</ArticleId>
            <ArticleId IdType="pubmed">17502468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bogousslavsky J., Hungerbühler J.P., Regli F., Graf H.J. Subacute Myelopathy as the Presenting Manifestation of Sarcoidosis. Acta Neurochir. 1982;65:193–197. doi: 10.1007/BF01405845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF01405845</ArticleId>
            <ArticleId IdType="pubmed">7180597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Durel C.-A., Marignier R., Maucort-Boulch D., Iwaz J., Berthoux E., Ruivard M., André M., Le Guenno G., Pérard L., Dufour J.-F., et al.  Clinical Features and Prognostic Factors of Spinal Cord Sarcoidosis: A Multicenter Observational Study of 20 BIOPSY-PROVEN Patients. J. Neurol. 2016;263:981–990. doi: 10.1007/s00415-016-8092-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-016-8092-5</ArticleId>
            <ArticleId IdType="pubmed">27007482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spencer T.S., Campellone J.V., Maldonado I., Huang N., Usmani Q., Reginato A.J. Clinical and Magnetic Resonance Imaging Manifestations of Neurosarcoidosis. Semin. Arthritis Rheum. 2005;34:649–661. doi: 10.1016/j.semarthrit.2004.07.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semarthrit.2004.07.011</ArticleId>
            <ArticleId IdType="pubmed">15692958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy O., Salazar-Camelo A., Jimenez J., Barreras P., Reyes M., Garcia M., Moller D., Chen E., Pardo C. Clinical and MRI Phenotypes of Sarcoidosis-Associated Myelopathy. Neurol. Neuroimmunol. Neuroinflamm. 2020;7:e722. doi: 10.1212/NXI.0000000000000722.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/NXI.0000000000000722</ArticleId>
            <ArticleId IdType="pmc">PMC7176244</ArticleId>
            <ArticleId IdType="pubmed">32269072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freda P.U., Post K.D. Differential Diagnosis of Sellar Masses. Endocrinol. Metab. Clin. N. Am. 1999;28:81–117. doi: 10.1016/S0889-8529(05)70058-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0889-8529(05)70058-X</ArticleId>
            <ArticleId IdType="pubmed">10207686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Langrand C., Bihan H., Raverot G., Varron L., Androdias G., Borson-Chazot F., Brue T., Cathebras P., Pinede L., Muller G., et al.  Hypothalamo-Pituitary Sarcoidosis: A Multicenter Study of 24 Patients. QJM. 2012;105:981–995. doi: 10.1093/qjmed/hcs121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/qjmed/hcs121</ArticleId>
            <ArticleId IdType="pubmed">22753675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tavee J.O., Karwa K., Ahmed Z., Thompson N., Parambil J., Culver D.A. Sarcoidosis-Associated Small Fiber Neuropathy in a Large Cohort: Clinical Aspects and Response to IVIG and Anti-TNF Alpha Treatment. Respir. Med. 2017;126:135–138. doi: 10.1016/j.rmed.2017.03.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2017.03.011</ArticleId>
            <ArticleId IdType="pubmed">28318820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoitsma E., Reulen J.P.H., de Baets M., Drent M., Spaans F., Faber C.G. Small Fiber Neuropathy: A Common and Important Clinical Disorder. J. Neurol. Sci. 2004;227:119–130. doi: 10.1016/j.jns.2004.08.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2004.08.012</ArticleId>
            <ArticleId IdType="pubmed">15546602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parambil J.G., Tavee J.O., Zhou L., Pearson K.S., Culver D.A. Efficacy of Intravenous Immunoglobulin for Small Fiber Neuropathy Associated with Sarcoidosis. Respir. Med. 2011;105:101–105. doi: 10.1016/j.rmed.2010.09.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2010.09.015</ArticleId>
            <ArticleId IdType="pubmed">20926271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoitsma E., De Vries J., Drent M. The Small Fiber Neuropathy Screening List: Construction and Cross-Validation in Sarcoidosis. Respir. Med. 2011;105:95–100. doi: 10.1016/j.rmed.2010.09.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2010.09.014</ArticleId>
            <ArticleId IdType="pubmed">20889323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hebel R., Dubaniewicz-Wybieralska M., Dubaniewicz A. Overview of Neurosarcoidosis: Recent Advances. J. Neurol. 2015;262:258–267. doi: 10.1007/s00415-014-7482-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-014-7482-9</ArticleId>
            <ArticleId IdType="pmc">PMC4330460</ArticleId>
            <ArticleId IdType="pubmed">25194844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colvin I.B. Audiovestibular Manifestations of Sarcoidosis: A Review of the Literature. Laryngoscope. 2006;116:75–82. doi: 10.1097/01.mlg.0000184580.52723.9f.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.mlg.0000184580.52723.9f</ArticleId>
            <ArticleId IdType="pubmed">16481814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoitsma E., Faber C.G., Drent M., Sharma O.P. Neurosarcoidosis: A Clinical Dilemma. Lancet Neurol. 2004;3:397–407. doi: 10.1016/S1474-4422(04)00805-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(04)00805-1</ArticleId>
            <ArticleId IdType="pubmed">15207796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burns T.M., Dyck P.J.B., Aksamit A.J., Dyck P.J. The Natural History and Long-Term Outcome of 57 Limb Sarcoidosis Neuropathy Cases. J. Neurol. Sci. 2006;244:77–87. doi: 10.1016/j.jns.2006.01.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2006.01.014</ArticleId>
            <ArticleId IdType="pubmed">16524595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jachiet V., Lhote R., Rufat P., Pha M., Haroche J., Crozier S., Dupel-Potier C., Psimaras D., Amoura Z., Cohen Aubart F. Clinical, Imaging, and Histological Presentations and Outcomes of Stroke Related to Sarcoidosis. J. Neurol. 2018;265:2333–2341. doi: 10.1007/s00415-018-9001-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-018-9001-x</ArticleId>
            <ArticleId IdType="pubmed">30109479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahévas M., Lescure F.X., Boffa J.-J., Delastour V., Belenfant X., Chapelon C., Cordonnier C., Makdassi R., Piette J.-C., Naccache J.-M., et al.  Renal Sarcoidosis: Clinical, Laboratory, and Histologic Presentation and Outcome in 47 Patients. Medicine. 2009;88:98–106. doi: 10.1097/MD.0b013e31819de50f.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0b013e31819de50f</ArticleId>
            <ArticleId IdType="pubmed">19282700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cozier Y.C., Berman J.S., Palmer J.R., Boggs D.A., Serlin D.M., Rosenberg L. Sarcoidosis in Black Women in the United States: Data from the Black Women’s Health Study. Chest. 2011;139:144–150. doi: 10.1378/chest.10-0413.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.10-0413</ArticleId>
            <ArticleId IdType="pmc">PMC3014690</ArticleId>
            <ArticleId IdType="pubmed">20595459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson M.A., Boan A.D., Lackland D.T. The Clinical Course of Sarcoidosis: Presentation, Diagnosis, and Treatment in a Large White and Black Cohort in the United States. Sarcoidosis Vasc. Diffus. Lung Dis. 2012;29:119–127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23461074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamata Y., Sato H., Joh K., Tsuchiya Y., Kunugi S., Shimizu A., Konta T., Baughman R.P., Azuma A. Clinical Characteristics of Biopsy-Proven Renal Sarcoidosis in Japan. Sarcoidosis Vasc. Diffus. Lung Dis. 2018;35:252–260. doi: 10.36141/svdld.v35i3.6655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.36141/svdld.v35i3.6655</ArticleId>
            <ArticleId IdType="pmc">PMC7170156</ArticleId>
            <ArticleId IdType="pubmed">32476910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Javaud N., Belenfant X., Stirnemann J., Laederich J., Ziol M., Callard P., Ronco P., Rondeau E., Fain O. Renal Granulomatoses: A Retrospective Study of 40 Cases and Review of the Literature. Medicine. 2007;86:170–180. doi: 10.1097/MD.0b013e3180699f55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0b013e3180699f55</ArticleId>
            <ArticleId IdType="pubmed">17505256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah S., Carter-Monroe N., Atta M.G. Granulomatous Interstitial Nephritis. Clin. Kidney J. 2015;8:516–523. doi: 10.1093/ckj/sfv053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ckj/sfv053</ArticleId>
            <ArticleId IdType="pmc">PMC4581373</ArticleId>
            <ArticleId IdType="pubmed">26413275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clive D.M., Vanguri V.K. The Syndrome of Tubulointerstitial Nephritis With Uveitis (TINU) Am. J. Kidney Dis. 2018;72:118–128. doi: 10.1053/j.ajkd.2017.11.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.ajkd.2017.11.013</ArticleId>
            <ArticleId IdType="pubmed">29429748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bergner R., Hoffmann M., Waldherr R., Uppenkamp M. Frequency of Kidney Disease in Chronic Sarcoidosis. Sarcoidosis Vasc. Diffus. Lung Dis. 2003;20:126–132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12870722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bergner R., Löffler C. Renal Sarcoidosis: Approach to Diagnosis and Management. Curr. Opin. Pulm. Med. 2018;24:513–520. doi: 10.1097/MCP.0000000000000504.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MCP.0000000000000504</ArticleId>
            <ArticleId IdType="pubmed">29965860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mrówka-Kata K., Kata D., Lange D., Namysłowski G., Czecior E., Banert K. Sarcoidosis and Its Otolaryngological Implications. Eur. Arch. Oto-Rhino-Laryngol. Off. J. Eur. Fed. Oto-Rhino-Laryngol. Soc. (Eufos) Affil. Ger. Soc. Oto-Rhino-Laryngol. Head Neck Surg. 2010;267:1507–1514. doi: 10.1007/s00405-010-1331-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00405-010-1331-y</ArticleId>
            <ArticleId IdType="pubmed">20617327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aubart F.C., Ouayoun M., Brauner M., Attali P., Kambouchner M., Valeyre D., Nunes H. Sinonasal Involvement in Sarcoidosis: A Case-Control Study of 20 Patients. Medicine. 2006;85:365–371. doi: 10.1097/01.md.0000236955.79966.07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.md.0000236955.79966.07</ArticleId>
            <ArticleId IdType="pubmed">17108780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawson W., Jiang N., Cheng J. Sinonasal Sarcoidosis: A New System of Classification Acting as a Guide to Diagnosis and Treatment. Am. J. Rhinol. Allergy. 2014;28:317–322. doi: 10.2500/ajra.2014.28.4061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2500/ajra.2014.28.4061</ArticleId>
            <ArticleId IdType="pubmed">25197919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edriss H., Kelley J.S., Demke J., Nugent K. Sinonasal and Laryngeal Sarcoidosis—An Uncommon Presentation and Management Challenge. Am. J. Med. Sci. 2019;357:93–102. doi: 10.1016/j.amjms.2018.11.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjms.2018.11.007</ArticleId>
            <ArticleId IdType="pubmed">30665498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duchemann B., Lavolé A., Naccache J.-M., Nunes H., Benzakin S., Lefevre M., Kambouchner M., Périé S., Valeyre D., Cadranel J. Laryngeal Sarcoidosis: A Case-Control Study. Sarcoidosis Vasc. Diffus. Lung Dis. 2014;31:227–234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25363223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rotman A., Maughan E.F., Rouhani M.J., Holroyd A., Ashcroft M., Al Yaghchi C., Sandhu G. Laryngeal Sarcoidosis at a Tertiary Airway Centre: Our Experience with 32 Patients. Clin. Otolaryngol. 2020 doi: 10.1111/coa.13679.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/coa.13679</ArticleId>
            <ArticleId IdType="pubmed">33274590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lhote R., Annesi-Maesano I., Nunes H., Launay D., Borie R., Sacré K., Schleinitz N., Hamidou M., Mahevas M., Devilliers H., et al.  Clinical Phenotypes of Extrapulmonary Sarcoidosis: An Analysis of a French, Multiethnic, Multicenter Cohort. Eur. Respir. J. 2020:2001160. doi: 10.1183/13993003.01160-2020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.01160-2020</ArticleId>
            <ArticleId IdType="pubmed">33093118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kreider M.E., Christie J.D., Thompson B., Newman L., Rose C., Barnard J., Bresnitz E., Judson M.A., Lackland D.T., Rossman M.D. Relationship of Environmental Exposures to the Clinical Phenotype of Sarcoidosis. Chest. 2005;128:207–215. doi: 10.1016/S0012-3692(15)37948-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0012-3692(15)37948-4</ArticleId>
            <ArticleId IdType="pubmed">16002937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judson M.A., Costabel U., Drent M., Wells A., Maier L., Koth L., Shigemitsu H., Culver D.A., Gelfand J., Valeyre D., et al.  The WASOG Sarcoidosis Organ Assessment Instrument: An Update of a Previous Clinical Tool. Sarcoidosis Vasc. Diffus. Lung Dis. 2014;31:19–27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24751450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bickett A.N., Lower E.E., Baughman R.P. Sarcoidosis Diagnostic Score. Chest. 2018;154:1052–1060. doi: 10.1016/j.chest.2018.05.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2018.05.003</ArticleId>
            <ArticleId IdType="pmc">PMC6859250</ArticleId>
            <ArticleId IdType="pubmed">29778660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agrawal A., Ghori U., Chaddha U., Murgu S. Combined EBUS-IFB and EBUS-TBNA vs. EBUS-TBNA Alone for Intrathoracic Adenopathy: A Meta-Analysis. Ann. Thorac. Surg. 2021 doi: 10.1016/j.athoracsur.2020.12.049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.athoracsur.2020.12.049</ArticleId>
            <ArticleId IdType="pubmed">33485918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernard C., Kodjikian L., Bancel B., Isaac S., Broussolle C., Seve P. Ocular Sarcoidosis: When Should Labial Salivary Gland Biopsy Be Performed? Graefes Arch. Clin. Exp. Ophthalmol. 2013;251:855–860. doi: 10.1007/s00417-012-2178-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00417-012-2178-2</ArticleId>
            <ArticleId IdType="pubmed">23100162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blaise P., Fardeau C., Chapelon C., Bodaghi B., Le Hoang P. Minor Salivary Gland Biopsy in Diagnosing Ocular Sarcoidosis. Br. J. Ophthalmol. 2011;95:1731–1734. doi: 10.1136/bjophthalmol-2011-300129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjophthalmol-2011-300129</ArticleId>
            <ArticleId IdType="pubmed">21900225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keijsers R.G.M., Grutters J.C. In Which Patients with Sarcoidosis Is FDG PET/CT Indicated? J. Clin. Med. 2020;9:890.  doi: 10.3390/jcm9030890.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9030890</ArticleId>
            <ArticleId IdType="pmc">PMC7141490</ArticleId>
            <ArticleId IdType="pubmed">32213991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rahmi A., Deshayes E., Maucort-Boulch D., Varron L., Grange J.D., Kodjikian L., Seve P. Intraocular Sarcoidosis: Association of Clinical Characteristics of Uveitis with Findings from 18 F-Labelled Fluorodeoxyglucose Positron Emission Tomography. Br. J. Ophthalmol. 2012;96:99–103. doi: 10.1136/bjo.2010.194514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjo.2010.194514</ArticleId>
            <ArticleId IdType="pubmed">21464036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan J.L., Fong H.K., Birati E.Y., Han Y. Cardiac Sarcoidosis. Am. J. Cardiol. 2019;123:513–522. doi: 10.1016/j.amjcard.2018.10.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjcard.2018.10.021</ArticleId>
            <ArticleId IdType="pubmed">30503798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshinaga K., Miyagawa M., Kiso K., Ishida Y. Japanese Guidelines for Cardiac Sarcoidosis. Ann. Nucl. Cardiol. 2017;3:121–124. doi: 10.17996/anc.17-00029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.17996/anc.17-00029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stern B.J., Royal W., Gelfand J.M., Clifford D.B., Tavee J., Pawate S., Berger J.R., Aksamit A.J., Krumholz A., Pardo C.A., et al.  Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol. 2018;75:1546. doi: 10.1001/jamaneurol.2018.2295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaneurol.2018.2295</ArticleId>
            <ArticleId IdType="pubmed">30167654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herbort C.P., Rao N.A., Mochizuki M. The members of the Scientific Commi International Criteria for the Diagnosis of Ocular Sarcoidosis: Results of the First International Workshop on Ocular Sarcoidosis (IWOS) Ocul. Immunol. Inflamm. 2009;17:160–169. doi: 10.1080/09273940902818861.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09273940902818861</ArticleId>
            <ArticleId IdType="pubmed">19585358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mochizuki M., Smith J.R., Takase H., Kaburaki T., Acharya N.R., Rao N.A. Revised Criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the Diagnosis of Ocular Sarcoidosis. Br. J. Ophthalmol. 2019;103:1418–1422. doi: 10.1136/bjophthalmol-2018-313356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjophthalmol-2018-313356</ArticleId>
            <ArticleId IdType="pubmed">30798264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosen Y. Four Decades of Necrotizing Sarcoid Granulomatosis: What Do We Know Now? Arch. Pathol. Lab. Med. 2015;139:252–262. doi: 10.5858/arpa.2014-0051-RA.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5858/arpa.2014-0051-RA</ArticleId>
            <ArticleId IdType="pubmed">25611109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Criado E., Sánchez M., Ramírez J., Arguis P., de Caralt T.M., Perea R.J., Xaubet A. Pulmonary Sarcoidosis: Typical and Atypical Manifestations at High-Resolution CT with Pathologic Correlation. RadioGraphics. 2010;30:1567–1586. doi: 10.1148/rg.306105512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/rg.306105512</ArticleId>
            <ArticleId IdType="pubmed">21071376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park H.J., Jung J.I., Chung M.H., Song S.W., Kim H.L., Baik J.H., Han D.H., Kim K.J., Lee K.-Y. Typical and Atypical Manifestations of Intrathoracic Sarcoidosis. Korean J. Radiol. 2009;10:623. doi: 10.3348/kjr.2009.10.6.623.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3348/kjr.2009.10.6.623</ArticleId>
            <ArticleId IdType="pmc">PMC2770817</ArticleId>
            <ArticleId IdType="pubmed">19885319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spagnolo P., Luppi F., Roversi P., Cerri S., Fabbri L.M., Richeldi L. Sarcoidosis: Challenging Diagnostic Aspects of an Old Disease. Am. J. Med. 2012;125:118–125. doi: 10.1016/j.amjmed.2011.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjmed.2011.06.003</ArticleId>
            <ArticleId IdType="pubmed">22269612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El Jammal T., Jamilloux Y., Gerfaud-Valentin M., Valeyre D., Sève P. Refractory Sarcoidosis: A Review. TCRM. 2020;16:323–345. doi: 10.2147/TCRM.S192922.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/TCRM.S192922</ArticleId>
            <ArticleId IdType="pmc">PMC7173950</ArticleId>
            <ArticleId IdType="pubmed">32368072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gousseff M., Mechaï F., Lecuit M., Lortholary O. Les granulomatoses systémiques d’origine infectieuse. La Rev. De Médecine Interne. 2008;29:15–27. doi: 10.1016/j.revmed.2007.09.037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.revmed.2007.09.037</ArticleId>
            <ArticleId IdType="pubmed">18054122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piotrowski W.J., Żądło P.P.L.J., Górski W., Kumor-Kisielewska A., Fijałkowski M., Kurmanowska Z., Marczak J., Gwadera Ł., Angowski W., Górski P., et al.  QuantiFERON-TB-GOLD In-Tube in Patients with Sarcoidosis. Adv. Respir. Med. 2018;86:234–239. doi: 10.5603/ARM.2018.0037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5603/ARM.2018.0037</ArticleId>
            <ArticleId IdType="pubmed">30378651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Sullivan C.E., Miller D.R., Schneider P.S., Roberts G.D. Evaluation of Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test by Using Respiratory and Nonrespiratory Specimens in a Tertiary Care Center Laboratory. J. Clin. Microbiol. 2002;40:1723–1727. doi: 10.1128/JCM.40.5.1723-1727.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.40.5.1723-1727.2002</ArticleId>
            <ArticleId IdType="pmc">PMC130650</ArticleId>
            <ArticleId IdType="pubmed">11980950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dhooria S., Gupta N., Bal A. Role of Xpert MTB/RIF in Differentiating Tuberculosis from Sarcoidosis in Patients with Mediastinal Lymphadenopathy Undergoing EBUS-TBNA: A Study of 147 Patients. Sarcoidosis Vasc. Diffus. Lung Dis. 2016;33:258–266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27758992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohshimo S., Guzman J., Costabel U., Bonella F. Differential Diagnosis of Granulomatous Lung Disease: Clues and Pitfalls: Number 4 in the Series “Pathology for the Clinician” Edited by Peter Dorfmüller and Alberto Cavazza. Eur. Respir. Rev. 2017;26:170012. doi: 10.1183/16000617.0012-2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/16000617.0012-2017</ArticleId>
            <ArticleId IdType="pubmed">28794143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramos-Casals M., Mañá J., Nardi N., Brito-Zerón P., Xaubet A., Sánchez-Tapias J.M., Cervera R., Font J. Sarcoidosis in Patients With Chronic Hepatitis C Virus Infection: Analysis of 68 Cases. Medicine. 2005;84:69–80. doi: 10.1097/01.md.0000157577.69729.e6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.md.0000157577.69729.e6</ArticleId>
            <ArticleId IdType="pubmed">15758836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chopra A., Nautiyal A., Kalkanis A., Judson M.A. Drug-Induced Sarcoidosis-Like Reactions. Chest. 2018;154:664–677. doi: 10.1016/j.chest.2018.03.056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2018.03.056</ArticleId>
            <ArticleId IdType="pubmed">29698718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen Aubart F., Lhote R., Amoura A., Valeyre D., Haroche J., Amoura Z., Lebrun-Vignes B. Drug-induced Sarcoidosis: An Overview of the WHO Pharmacovigilance Database. J. Intern. Med. 2019 doi: 10.1111/joim.12991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/joim.12991</ArticleId>
            <ArticleId IdType="pubmed">31612562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouvry D., Mouthon L., Brillet P.-Y., Kambouchner M., Ducroix J.-P., Cottin V., Haroche J., Viallard J.-F., Lazor R., Lebargy F., et al.  Granulomatosis-Associated Common Variable Immunodeficiency Disorder: A Case-Control Study versus Sarcoidosis. Eur. Respir. J. 2013;41:115–122. doi: 10.1183/09031936.00189011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00189011</ArticleId>
            <ArticleId IdType="pubmed">22903958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El Jammal T., Pavic M., Gerfaud-Valentin M., Jamilloux Y., Seve P. Sarcoidosis and Cancer: A Complex Relationship. Front. Med. 2020 doi: 10.3389/fmed.2020.594118. Accepted for publication.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmed.2020.594118</ArticleId>
            <ArticleId IdType="pmc">PMC7732692</ArticleId>
            <ArticleId IdType="pubmed">33330555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lococo F., Muoio B., Chiappetta M., Nachira D., Petracca Ciavarella L., Margaritora S., Treglia G. Diagnostic Performance of PET or PET/CT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours According to Published Meta-Analyses. Contrast Media Mol. Imaging. 2020;2020:1–7. doi: 10.1155/2020/5282698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2020/5282698</ArticleId>
            <ArticleId IdType="pmc">PMC7196984</ArticleId>
            <ArticleId IdType="pubmed">32405280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Law L.Y., Riminton D.S., Nguyen M., Barnett M.H., Reddel S.W., Hardy T.A. The Spectrum of Immune-Mediated and Inflammatory Lesions of the Brainstem: Clues to Diagnosis. Neurology. 2019;93:390–405. doi: 10.1212/WNL.0000000000008015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.0000000000008015</ArticleId>
            <ArticleId IdType="pubmed">31451586</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
